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CHAPTER 1: CIRRHOSIS: A REVIEW 
INTRODUCTION 
Cirrhosis is a common condition and results in severe morbidity and mortality. In South 
Africa, the mortality rate for cirrhosis in the white population was 6.9 per 100 000 in 1980, 
down from 11 .7 per 100 000 in 1970 (Wyndham 1985). There are no figures for other 
population groups but a report from Durban (O'Keefe et al 1982) suggests that cirrhosis is 
common in the black population of Natal and cirrhosis is the eighth most common disease 
encountered in King Edward VIII Hospital. 
Many studies have been done on survival or mortality rates for cirrhosis in both compensated 
and decompensated states in other countries (D'Amico et al 1986; Gines et al 1987). In the 
United States, cirrhosis has shown a decrease in mortality whilst there has been an increase 
in morbidity over the past two decades (Dufour et al 1993; Noble et al 1993). 
Alcohol is the most common cause of cirrhosis in the United States and United Kingdom 
(Friedman et al 1992). The study of Saunders et al (1981) reported a high incidence of 
alcoholic cirrhosis in west Birmingham, UK, with a significant rise between 1969 and 1976. In 
the study of O'Keefe et al (1982) in Durban, the majority of their cirrhotic patients admitted to 
alcohol abuse and weekend bingeing. In the study of Seebaran et al (1988), also in Durban, 
alcohol was the major cause of cirrhosis in the Indian patients he studied. 
In contrast to the importance of alcohol in western countries, it has been reported that 
chronic hepatitis B virus infection is responsible for most cases of cirrhosis in Africa and Asia 
(Sherlock and Dooley 1992; Dusheiko & Hoofnagle 1991). There appear however to be no 
reports directly comparing the prevalence of viral and alcoholic cirrhosis in South Africa. 
DEFINITION OF CIRRHOSIS 
The definition which we consider most appropriate is that of Anthony et al (1977) , which 
defines cirrhosis as a diffuse process characterised by fibrosis and the conversion of normal 
liver architecture into structurally abnormal nodules- Whatever the aetiology of the liver injury, 
cirrhosis represents the end-stage histological pattern of the injury. Although the diagnosis of 
cirrhosis is ultimately histological , clinical and biochemical changes and the complications 
that arise from it allow a reasonably confident clinical diagnosis to be made. 
However, a clinical diagnosis of cirrhosis made during life has a sensitivity of only 60%, 
suggesting that many cases of cirrhosis are missed during life (Dufour et al 1993). Stated 
differently, the true prevalence of cirrhosis is unknown because only 60% of patients with 
cirrhosis have signs or symptoms of liver disease. Some of the other 40% are discovered on 
routine examination, on examination for an unrelated complaint, or at autopsy (Dufour et al 
1993, Conn & Attenbury 1993). 
CLASSIFICATION 
Currently two classifications, morphological and aetiological , are used for cirrhosis: The 
morphologic classification refers to the gross and microscopic appearances of the liver and is 
useful in studying patterns epidemiologically and, to some extent in correlating them, with the 
underlying aetiology. 
2 
1. Morphological classification 
There are three morphologic forms: micronodular, macronodular and mixed cirrhosis. 
a) Micronodular cirrhosis 
The regularity of the nodules is an important feature of this form of cirrhosis. They are all or 
nearly all less than 3 mm in diameter. These micronodules are about one lobule in size, lack 
normal lobular organisation and are surrounded by fibrous tissue. This form of cirrhosis is 
characteristic of alcoholic cirrhosis (which is sometimes known as Laennec cirrhosis, after 
Laennec who described it in 1826). In micronodular cirrhosis, the liver itself is often normal-
sized or enlarged, particularly when there is associated steatosis. 
b) Macronodular cirrhosis 
This is characterised by a variation in nodule size with most nodules more than 3 mm in 
diameter, and many as large as several centimetres. There may be normal lobules within 
some of the macronodules. The macronodules may be divided by slender and sometimes 
incomplete septa that link portal tracts, on the other hand large macronodules in a coarsely 
scarred liver may be surrounded by broad fibrous septa. This is characteristic of cirrhosis 
associated with viral hepatitis. In macronodular cirrhosis, the size of the liver may be normal 
but is often reduced. 
c) Mixed cirrhosis 
This form is characterised by the presence of both micro- and macronodules in 
approximately equal proportions. 
The morphologic forms of cirrhosis may suggest possible aetiology but it is known that 
micronodular cirrhosis may progress to macronodular cirrhosis in the same patient 
(Fauerholdt et al 1983). Thus it may be impossible to link nodular size to a particular 
aetiological agent and in view of this, a direct aetiological classification would appear to be 
more appropriate. 
2. Aetiological classification 
The aetiological classification shown below (Table 1.1) has been adapted from two sources: 
Erlinger & Benhamou (1991) and Anthony et al (1977) . 
This classification divides the aetiology of cirrhosis into 3 broad groups: 
1. Established aetiological agents of cirrhosis 
2. Agents which have an association with cirrhosis but a causal relationship has not 
been proven 
3. Cirrhosis for which the aetiology is not known. 
1. Cirrhosis from established aetiological agents 
a) Alcohol 
b) Viral hepatitis including HBV, HDV and HCV 
c) Metabolic disorders, e.g. iron overload, Wilson's disease, alpha-1 antitrypsin 
deficiency and rare inherited disorders, e.g. galactosaemia 
d) Biliary disease 
i) lntrahepatic biliary obstruction 
ii) Extrahepatic biliary obstruction. Primary biliary cirrhosis and primary sclerosing 
cholangitis are included in this group. 
e) Autoimmunity - autoantibodies are found in serum and other immune diseases 
may be present 
f) Venous outflow obstruction including veno-occlusive disease, Budd-Chiari 
syndrome and cardiac failure. 
g) Toxins and therapeutic drugs, e.g. certain pyrrolizidine alkaloids, methotrexate 
and alpha methyldopa. 
h) Intestinal bypass operation for obesity. 
i) Others - syphilis and sarcoidosis are included in this rare subdivision. 
2. Unproven causes 
a) Malnutrition - this is a doubtful cause of cirrhosis in man. Protein deficiency is 
known to cause gross fatty change but it does not lead to chronic liver disease. 
b) Schistosomiasis is known to cause diffuse extensive hepatic fibrosis. Whether 
cirrhosis can result from schistosomiasis without other aetiological agent is not 
established. 
3. Cirrhosis of unknown aetiology 
a) With well-defined pattern - Indian childhood cirrhosis. 
b) With no well-defined pattern - Cryptogenic cirrhosis. 
Table 1.1. Aetiological classification of cirrhosis 
CLINICAL FEATURES 
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The clinical features of cirrhosis have been well described and may differ in different races. 
There is some evidence that the classic features of cirrhosis seen in white patients differ from 
those seen in black patients (Wicks et al 1977; O'Keefe et al 1982), whereas those seen in 
coloured patients in Cape Town, particularly the cutaneous and endocrine features, are 
similar to those seen in white patients (Kirsch 1985). Clinical features that are commonly 
found in western patients with alcoholic cirrhosis but uncommonly in black patients are listed 
in Table 1.2 (Friedman et al 1992). Table 1.3 shows the symptoms and clinical findings 
respectively found in black patients (Kirsch 1985). 
Patients with cirrhosis may be asymptomatic or they may present with non-specific 
symptoms such as lethargy, loss of weight and tiredness. Other patients may present with 
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Malaise, lethargy and dyspepsia 80% 
Loss of libido 60% 
Fever 3-10% 
Pigmentation 25% 
Spider naevi 50% 
Dupuytren's contractures 10-30% 
Gynaecomastia & testicular atrophy 20-30% 
Table 1.2. Incidence of signs & symptoms of alcoholic cirrhosis in western patients (adapted 
from Friedman et al 1992).) 
Symptoms 
Swelling of the body 60% Weakness 20% 
Abdominal pain 40% Haematemesis 15% 
Weight loss 30% Jaundice 10% 
Signs 
Hepatomegaly 70% Clubbing 13% 
Ascites and oedema 54% Parotid swelling 12% 
Emaciation 36% White nails 8% 
Splenomegaly 36% Testicular atrophy 7% 
Jaundice 35% Gynaecomastia 1% 
Abdominal veins 15% Spider naevi 1% 
Mental disturbance 14% Palmar erythema 1% 
Table 1.3. Incidence of symptoms and physical signs in black patients with cirrhosis 
(adapted from Kirsch 1985). 
florid signs of chronic liver disease and/or one or more of the major complications of 
cirrhosis. The former are known as compensated cirrhotics as opposed to the 
decompensated cirrhotics who present with established complications. 
LABORATORY FINDINGS 
Biochemical and haematological findings differ according to whether the patient is 
compensated or not. In compensated cirrhotics, there may be no biochemical or 
haematological changes with the possible exception of a low serum albumin and increased 
globulin. There may be a high aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT). One may find a mild normochromic anaemia which is often 
macrocytic. Both an AST/ALT ratio of more than two and a macrocytosis are commonly 
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found in alcoholic liver disease and may suggest alcohol as the cause of the illness. These 
findings are however of low specificity. Bilirubin , alkaline phosphatase (ALP) and gamma 
glutamyl transpeptidase (GGT) are usually normal in compensated cirrhosis . 
In decompensated cirrhosis, biochemical and haematological derangements are commonly 
found. A low albumin and raised globulin are present, resulting in a reversed albumin/globulin 
ratio . The AST, ALT, ALP and GGT are often elevated . The bilirubin is usually elevated and 
there may be clinical jaundice. The degree of these abnormalities in biochemistry may be 
related to the severity of the liver damage and also to the presence or absence of hepatitis at 
the time of investigation. The international normalised ration (INR) is often raised . Anaemia is 
frequent and is usually macrocytic. Leukopaenia and thrombocytopaenia may be found and 
may relate to hypersplenism. Electrolytes are usually normal but hyponatraemia is frequently 
found. (Conn & Attenbury 1993) 
DIAGNOSIS 
Decompensated cirrhosis can be suspected on clinical grounds; with typical laboratory 
findings and signs of complications, a diagnosis can be confidently made. However, 
compensated cirrhosis usually requires a liver biopsy for diagnosis as clinical findings may be 
confined to a small or large liver with or without an enlarged spleen. Imaging is used to 
evaluate a patient with cirrhosis but is not an accepted tool for diagnosis of cirrhosis although 
the finding of an irregular or shrunken liver is suggestive. 
SPECIAL INVESTIGATIONS 
U ltrasonog raphy 
Ultrasound examination is used in the complete evaluation of patients with cirrhosis for the 
following reasons: 
1. Assessment of fiver size and shape- This is useful when examination cannot accurately 
delineate liver size and shape, e.g. when the liver is displaced inferiorly by hyperinflated 
lungs, in the presence of ascites or in obese patients. 
2. Early detection of hepatocellular carcinoma- Ultrasound can pick up early hepatocellular 
carcinoma, which will appear as a focal area of different echogenicity. It is however less 
sensitive than computerised tomographic scanning (CT) in tumour detection and staging 
(Redhead & Olliff 1995). 
3. Detection of small amounts of ascites- Ultrasonography can detect volumes of ascites as 
small as 100 ml, and is far more sensitive than clinical assessment. 
4. Diagnosis of moderate-severe steatosis with cirrhosis- Ultrasonography may suggest 
steatosis by demonstrating reduced echogenicity. 
5. Evaluation of portal hypertension Ultrasound allows the measurement of portal vein 
diameter; a diameter in excess of 15 mm is said to be diagnostic of portal hypertension. 
This has a specificity of 100% and sensitivity of about 50%. The presence of collateral 
veins can be detected by ultrasound in about 90% of patients with portal hypertension 
(Erlinger et al 1991 ). Splenomegaly, though not specific for portal hypertension, is also 
detected on ultrasound. 
6. Occlusion of portal or hepatic veins- Ultrasound, particularly when combined with Doppler 




A CT examination is not as useful as ultrasound in the evaluation of cirrhosis , except when 
hepatocellular carcinoma is suspected . It gives a better view of the extent of the tumour, 
especially if resection is planned. It is less sensitive and less specific than ultrasound in 
evaluation of portal hypertension (Erlinger et al 1991 ). 
Endoscopy 
Endoscopic examination is performed to diagnose oesophageal varices and to determine 
their size and extent. The varices can be graded, which may be of prognostic importance in 
assessing risk of rebleeding . Additionally it allows the recognition of portal hypertensive 
gastropathy and of peptic ulcer which are common in cirrhosis. Where biliary tract pathology 
is suspected, it may be coupled with endoscopic retrograde cholangiopancreatography 
(ERCP). 
Liver biopsy 
Liver biopsy is very important in the diagnosis of cirrhosis. It may suggest aetiology and 
allows assessment of inflammatory activity and of the extent of the disease. It is also 
important for the follow-up of most liver diseases. The biopsy may be performed by four 
routes : i) percutaneous liver biopsy, either bl ind or ultrasound-guided; ii) transvenous liver 
biopsy which is usually done via the transjugular approach; iii) laparascopic needle biopsy 
and iv) wedge biopsy at laparotomy or minilaparotomy. 
The blind percutaneous liver biopsy is most commonly employed and is a safe procedure 
with a mortality rate of 0.01%. In the presence of minor coagulation problems, a plugged 
percutaneous liver biopsy can be done; in this technique, a Gelfoam plug is injected into the 
needle track to prevent bleeding. Additional coagulation support with fresh frozen plasma or 
platelets should however be given (Desmet & Fevery 1995). Ultrasound-guided biopsy is 
indicated for focal lesions. A transvenous liver biopsy is recommended in the presence of 
ascites or coagulopathy, in the assessment of hepatic vein obstruction and where portal 
pressure measurements are desired. 
The diagnostic usefulness of the biopsy is maximised if there is close co-operation between 
the clinician and the pathologist. The clinician needs to supply all the relevant clinical and 
biochemical data as well as an adequate specimen to enable the pathologist to plan the 
processing and staining of the specimen. The biopsy specimen is stained with haematoxylin 
and eosin for conventional histopathological assessment. In specific cases, special stains are 
essential to the correct assessment (Desmet & Fevery 1995). These include: 
1. Stains for reticulin and collagen which are important for accurate assessment of 
architectural changes and excessive matrix formation . These include the silver stain, 
Sirius red , chromotrope aniline blue, Masson's trichrome and Von Giesen stains. 
2. Perl's stain for iron. 
3. Shikata's orcein stain for hepatitis B surface antigen in hepatocytes. 
4. lmmunohistochemical stains for alpha-1 antitrypsin and viral antigens including HBsAg, 
HBcAg, HBeAg, hepatitis C, hepatitis D, herpes and cytomegalovirus (CMV) and an ever-
increasing range of other applications. 
5. Special stains and techniques may be applied to visualise specific features, e.g . amyloid 
is demonstrated with Congo Red under polarised light for amyloid ; porphyrin crystals in 
erythropoietic protoporphyria may be viewed under polarised light or ultraviolet light. 
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6. Electron microscopy can be applied for further studies of biopsy specimens but is mainly 
used for research purposes. 
7. Biochemical measurements of iron and copper are important in the assessment of 
haemochromatosis and Wilson's disease. 
DIFFERENTIAL DIAGNOSIS 
1. Differential diagnosis of compensated cirrhosis 
One should consider conditions that cause abnormal liver function tests or portal 
hypertension such as: 
i) Chronic hepatitis including hepatitis B and C virus, autoimmune hepatitis, Wilson's disease, 
alpha-1 antitrypsin deficiency and drug-induced chronic hepatitis. Liver biopsy in these 
conditions may give the correct diagnosis. 
ii) Extrahepatic portal vein thrombosis and presinusoidal intrahepatic portal vein thrombosis. 
Included amongst these are congenital hepatic fibrosis, hepatic schistosomiasis and 
regenerative nodular hyperplasia. Ultrasound examination may detect extrahepatic portal 
vein thrombosis and a biopsy is necessary for the intrahepatic causes. 
2. Differential diagnosis of decompensated cirrhosis 
There is a wide differential diagnosis in the patients with decompensated cirrhosis, who may 
present with one or more complications such as ascites, gastrointestinal bleeding and 
encephalopathy. 
The differential diagnosis for ascites includes other chronic liver diseases, e.g. Budd-Chiari 
syndrome and veno-occlusive disease, as well as constrictive pericarditis. Ultrasound 
examination is useful in Budd-Chiari syndrome in which a markedly enlarged caudate lobe 
will be seen as well as abnormalities of the hepatic veins. Hepatic venography is often useful 
for chronic veno-occlusive disease, which has been seen following consumption of herbal 
teas containing pyrrolizidine alkaloids, chemotherapy for leukaemia and after hepatic 
irradiation. Liver biopsy is necessary for final diagnosis. Constrictive pericarditis 
characteristically causes gross ascites and hepatomegaly but no jaundice. The diagnosis can 
be made on clinical signs, by the recognition of pericardia! calcification on radiographs, 
echocardiography, and if necessary, cardiac catheterisation. 
Malignancy can also cause ascites. This may be a metastatic liver malignancy or a peritoneal 
malignancy, or occasionally, hepatocellular carcinoma. Ascitic fluid cytology, ultrasound 
and/or CT scan of the liver with guided liver biopsy is needed for diagnosis. Peritoneal biopsy 
may be necessary. Tuberculous peritonitis can present with ascites and the diagnosis is 
made on the basis of ascitic fluid analysis and peritoneal biopsy. Transudative ascites may 
be encountered in cardiac failure, renal failure, the nephrotic syndrome and with severe 
hypoalbuminaemia. 
Gastrointestinal bleeding results from oesophageal varices and portal hypertensive 
gastropathy in cirrhosis as well as from peptic ulcer disease which is common in cirrhosis. In 
addition, bleeding can be from gastric erosions and occasionally from rectal varices. 
Endoscopy will determine the cause and the site of the bleeding. 
Hepatic encephalopathy also has a wide differential diagnosis but the diagnosis can be 
narrowed down on history and other clinical findings. The differential diagnosis can be 
included in four groups of conditions - metabolic encephalopathies, toxic encephalopathies, 
8 
intracranial lesions and neuropsychiatric disorders (Riordan & Williams 1997). Metabolic 
encephalopathies include hypoglycaemia, electrolyte imbalance, hypoxia and uraemia. Blood 
biochemical analysis with clinical findings confirms the diagnosis. Toxic encephalopathies 
include alcohol intoxication, alcohol withdrawal and Wernicke-Korsakoff syndrome. 
Psychoactive drugs and certain toxins, e.g . heavy metals, may give a similar picture. Red 
blood cell transketolase, blood alcohol levels, therapeutic response to thiamine and 
toxicology will confirm the diagnosis. lntracranial lesions include subarachnoid, subdural and 
intracerebral haemorrhages, infarction, tumour abscess, meningitis and encephalitis. Lumbar 
puncture, CT scanning and/or angiography establish the diagnosis. Neuropsychiatric 
disorders may also present like hepatic encephalopathy and tests for organic brain 
syndromes are needed for diagnosis. 
COMPLICATIONS 
It is well known that once patients develop any of the major complications of cirrhosis , i.e. 
decompensation, the prognosis is poor. Indeed, they should be considered for liver 
transplantation . It has been estimated that the 5 year survival for patients who develop any of 
these complications is about 16% (Gines et al 1987). Decompensated patients present 
frequently to hospital for admission but studies of the frequency or reasons for admission in 
these patients and of the outcome of hospital treatment are lacking. The major complications 
of cirrhosis are ascites, spontaneous bacterial peritonitis, portal hypertensive variceal 
bleeding and hepatic encephalopathy, which are briefly discussed below. 
Ascites 
The formation of ascites in cirrhosis results from a combination of abnormalities in renal 
function as well as over-activity of the vasoconstrictor and anti-natriuretic systems which 
cause fluid retention and alter the haemodynamics of the portal and splanchnic circulation. 
These changes promote accumulation of the retained fluid in the peritoneal cavity (Gines et 
al 1997). 
Sodium retention is the major factor in the pathogenesis of ascites formation and oedema as 
it causes extracellular volume expansion. The retention is secondary to increased sodium 
reabsorption from the renal tubules. Many factors are involved in the increased reabsorption 
but the most important are hyperaldosteronism and enhanced renal sympathetic activity. 
Cirrhosis causes marked structural abnormalities in the liver which result in severe 
disturbance of hepatic and splanchnic circulation. Deposition of fibrous tissue and nodular 
formation alter normal vascular architecture and result in increased resistance to portal blood 
flow. The increased vascular resistance has effects both in the portal venous system and on 
the arterial side of the splanchnic circulation. In the venous side, there is development of 
portal hypertension and formation of collateral veins with portal systemic shunting of blood. 
On the arterial side there is marked arterial dilatation which increases portal venous inflow 
and contributes to increased pressure in the portal venous system. These changes 
predispose to ascites formation by increasing the filtration of fluid . 
Theories of ascites formation 
Two different mechanisms have been proposed for ascites formation, namely the overfill and 
the underfill theory. 
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1. The overfill theory 
This theory suggests that there is a primary renal defect in sodium excretion which results in 
hypervolaemia. Reduction in systemic vascular resistance and increased cardiac output 
develop as a result of increased fluid retention . As the volume of the retained fluid increases, 
there is increased filtration of fluid into the interstitial space resulting in ascites and oedema. 
2. Underfill theory 
This theory proposes that sodium retention is a homeostatic response of the kidney to an 
underfilling of the arterial circulation secondary to arterial vasodilatation. The underfilling 
causes reduction in the effective arterial blood volume with a resultant increase in 
vasoconstrictive response and elevated anti-natriuretic factor secretion to compensate for the 
arterial underfilling. Since fluid is continuously leaking into the peritoneal cavity, the retained 
fluid cannot fill the intravascular compartment adequately and does not suppress sodium-
retaining signals, thus creating a vicious cycle (Gines et al , 1997). 
Treatment of ascites 
Patients should be considered for transplantation . Those awaiting transplantation and those 
unsuitable for it are managed by dietary sodium restriction and diuretics. The diuretics used 
are a combination of furosemide and spironolactone and the dose can be increased to a 
maximum of 160 mg furosemide per day and 400 mg spironolactone per day, depending on 
the response. Dietary sodium restriction is the most important aspect as diuretics are 
essentially ineffective in the presence of a high sodium intake. This treatment is effective in 
controlling ascites or fluid overload in about 90% of patients (Runyon 1998). 
Fewer than 10% of patients do not respond to this treatment and they should be considered 
for second-line therapy. These patients have refractory ascites which is defined as fluid 
overload unresponsive to sodium restricted diets and high-dose diuretic treatment. They 
have a poor prognosis with 50% of patients with refractory ascites dying within 6 months and 
75% dying within 12 months. 
Treatment options for refractory ascites include: 
• Serial therapeutic paracentesis. 
• Liver transplantation 
• Peritoneal venous shunt 
• Transjugular intrahepatic portal systemic stent shunt (TIPSS) (Runyon 1997). 
These treatment options should be reserved for the patients who have failed adequate 
diuretic treatment. 
Serial paracentesis should be performed as needed, which is usually every 2 weeks. Post-
paracentesis albumin infusion may be unnecessary where a volume less than 5 litres is 
removed, albumin is expensive and has not been shown to decrease morbidity and mortality 
(Runyon 1997). However, where large volumes are withdrawn, albumin may be administered 
to maintain euvolaemia and to prevent renal decompensation. 
Peritoneovenous shunting should be reserved for those patients who are not transplant 
candidates and are unsuitable for serial paracentesis because of previous abdominal surgery 
or inability to attend the hospital regularly. 
TIPSS was initially recommended for treatment of variceal bleeding. It is now listed as one of 
the treatment modalities for refractory ascites. In uncontrolled trials, control in patients with 
diuretic-resistant ascites was achieved with this procedure (Runyon 1997). 
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Spontaneous bacterial peritonitis 
A major complication of cirrhotic patients with ascites is spontaneous bacteria l peritonitis 
(SBP) . It is defined as bacterial infection of ascitic fluid in the absence of any intra-
abdominal , surgically-remediable source of infection. 
Several factors may predispose to SBP , including bacterial translocation across the gut wall 
promoted by a deficiency in local host immune defences, increased permeability of the 
intestinal mucosal barrier and intestinal bacterial overgrowth (Guarner & Soriano 1997). The 
deficient host immune defences described in cirrhotics include decreased reticule-endothelial 
phagocytic activity, deficient opsonisation by the ascitic fluid and qualitative neutrophil 
dysfunction (Gomez et al 1994; Runyon 1998). Factors which facilitate the development of 
SBP are more severe liver disease, gastrointestinal haemorrhage, an ascitic fluid protein less 
than 1 Og/1 and a previous episode of SBP. 
A high index of suspicion is needed for the diagnosis of SBP. The diagnosis is confirmed by 
the determination of the ascitic fluid neutrophil count and on direct culture - fluid should be 
inoculated directly into blood-culture bottles. An ascitic fluid neutrophil count of more than 
250 cells/ml is considered diagnostic of ascitic fluid infection. Cirrhotic patients with SBP 
frequently do not have typical signs of infection, and fluid should be aspirated and examined 
even when there is minimal suspicion of infection. It is suggested that an ascitic fluid analysis 
and culture should be performed in the following circumstances (Guarner & Soriano 1997): 
• new onset ascites 
• ascites present at the time of admission to hospital 
• ascites accompanied by cl inical signs and symptoms of infection 
• ascites associated with a deterioration in clinical condition, including the development of 
impaired renal function 
Third-generation cephalosporins and quinolones are the drugs of choice for treatment of SBP 
with a cure rate of more than 80%. Prophylactic selective intestinal decontamination with oral 
ofloxacin is useful in the prevention of SBP in high-risk patients, particularly those with 
repeated episodes (Guarner & Soriano 1997). It has been suggested that selective 
decontamination of the bowel with ofloxacin may predispose to the development of 
quinolone-resistant SBP in the future ; practice has however shown this to be extremely 
uncommon (Llovet et al 1997). 
The prognosis for patients with SBP is poor and 20-40% of patients die during that 
hospitalisation, usually from other complications of the underlying liver disease, such as 
gastrointestinal bleeding , renal failure or liver failure . 
In the long term, 40-70% of survivors of an episode of SBP will develop another episode of 
SBP within one year. One-year survival after the first episode is 30-40% and is worse in 
patients with Child-Pugh Class C. In view of the poor prognosis, survivors of an episode of 
SBP should be considered for liver transplantation (Guarner & Soriano 1997). 
Variceal bleeding 
The most serious complication of portal hypertension is bleeding from ruptured oesophageal 
varices, which carries a mortality of 30-50%. In the presence of portal hypertension, collateral 
vessels open in the gastro-oesophageal , retroperitoneal, peri-anal and para-umbilical areas, 
as well as in the peritoneum and in areas of surgical anastamosis. Their effect is partially to 
decompress the portal system. Despite the presence of collaterals, a high portal pressure is 
maintained by increased splanchnic arterial flow. Distended gastro-oesophageal collaterals 
or varices are particularly hazardous in view of their propensity to rupture. The risk of 
bleeding from varices increases with severity of liver disease, variceal size and has been 
11 
correlated with the presence of so-called "cherry red spots", visible endoscopically, on the 
varices. It is also related to the pressure gradient between the portal vein and the inferior 
vena cava. Where less than 12 mm Hg, bleeding is unlikely, and the risk of bleeding is 
greatly reduced if a pressure reduction of 20% or more can be achieved in the portal system 
with therapy. 
About 30% of patients with oesophageal varices will eventually bleed and the mortality is 
50% with the first bleed. Patients who have bled once are likely to bleed again (Stanley & 
Hayes 1997). Not all gastrointestinal haemorrhage in the patient with varices is variceal in 
origin. Other causes include portal hypertensive gastropathy, also related to portal 
hypertension, or to causes such as peptic ulceration or gastritis; occasionally from varices in 
other sites such as the duodenum or rectum. 
Management of variceal bleeding 
Early resuscitation with colloid and blood is most important. Tracheal intubation may be 
required to protect the airway, particularly in the presence of a major haemorrhage or of 
encephalopathy. 
Therapeutic endoscopy has been demonstrated to be the most efficacious form of therapy. It 
allows accurate identification of the source of bleeding followed by control of bleeding by 
injection sclerotherapy or variceal banding. Band ligation rather than sclerotherapy is now 
recommended , as, in comparison with sclerotherapy, it has been shown to reduce 
complications, speed the rate of variceal eradication, reduce bleeding rates and to reduce 
mortality (Stanley & Hayes 1997). 
Pharmacological management with modern agents shows the same success rate as 
sclerotherapy in the immediate control of acute bleeding. Treatment can be initiated on 
admission to stabilise the patient prior to endoscopy. Vasopressin and its analogues are 
associated with significant side effects and are contraindicated in patients with known or 
suspected ischaemic cardiac disease. By comparison, somatostatin and its synthetic 
analogue octreotide are associated with a lower rate of complications and of side-effects. 
Octreotide is longer acting than somatostatin. Both are given as infusions. (Burroughs et al 
1998). Pharmacological agents are useful when endoscopy is not available, but endoscopy 
should be arranged as soon as possible to confirm the source of the bleeding and to perform 
definitive treatment. 
Balloon tamponade with the Sengstaken-Blakemore tube is life-saving in severe bleeding but 
placement by inexperienced people is associated with a 6-20% mortality rate from 
complications which include oesophageal perforation and pulmonary aspiration (Stanley & 
Hayes 1997). 
TIPSS is the treatment of choice for the 10-20% of patients in whom endoscopic 
management fails. Failure may be defined as the occurrence of further variceal bleeding after 
two endoscopic treatments during a single hospital admission for an acute bleeding episode. 
TIPSS is however associated with hepatic encephalopathy which develops in about 20% of 
patients, and is frequently of temporary benefit only because of shunt occlusion. 
Surgical portal systemic shunting is highly effective in the control of variceal haemorrhage, 
but is associated with a high rate of encephalopathy which has severely restricted its use. It 
has now largely been replaced by TIPSS but has a place in the management of severe, 
uncontrolled haemorrhage where TIPSS is unsuitable, as does oesophageal transection and 
devascularisation. Both represent major surgery in the decompensated patient and are 
associated with a high mortality. 
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Secondary prophylaxis 
Rebleeding occurs in most patients, usually within a few weeks of the initial bleed. To 
prevent rebleeding , endoscopic variceal eradication by band ligation is recommended. 
Pharmacological agents are also used to prevent rebleeding . Beta-blockers are the drugs of 
choice, specifically non-cardioselective beta-blockers such as propranolol. They decrease 
portal pressure by reducing portal inflow as a result of a decrease in cardiac output caused 
by blQckade of cardiac 13-1 adrenoreceptors, as well as by causing splanchnic 
vasocon triction secondary to blockade of vasodilatory 13-2 adrenoreceptors in the splanchnic 
vasculature. or this reason , cardio-selective beta-blockers are less effective in reducing 
portal pressure han non-selective beta-blockers (Garcia-Pagan & Bosch 1997). 
Beta-blockers appea to lower the risk of bleeding by about 40% and mortality rates by 20%. 
It has been suggeste hat beta-blockers and sclerotherapy have similar effects on the rate 
of rebleeding and that tti e is no benefit in combining the two, compared to the use of one 
alone; further studies are i regress to provide more information on this. (Stanley & Hayes 
1997, Garcia & Bosch 1991) Addition of nitrates to beta-blockers has been reported to 
provide additional benefit. 
Primary prophylaxis of variceal leeding 
Patients known to have varices may be can~ dates for primary prophylaxis, and possibly all 
cirrhotic patients should be endoscoped biennially to detect their presence. Beta-blockers are 
the drugs of choice and it has been claimed that the risk of bleeding is reduced by 45%. 
Nitrates may be used as alternatives to beta-bloc ers in patients who do not tolerate them 
and there are reports that a combination of beta-blockers and nitrates are superior to beta-
blockers alone. Endoscopy with sclerotherapy is not recommended in primary prophylaxis 
since many patients will never bleed and sclerotherapy is associated with complications. 
Gastric varices and portal hypertensive gastropathy 
Gastric varices may also bleed and are more difficult to control endoscopically than those in 
the oesophagus. Endoscopic treatment should be attempted if the varices are in a hiatus 
hernia, or in the proximal part of the lesser curvature in combina ion with oesophageal 
varices. For other gastric varices, pharmacological treatment is used; if unsuccessful, early 
TIPSS or shunt surgery is recommended. 
Portal hypertensive gastropathy is the term used to describe the intensely hyperaemic gastric 
mucosa which may be encountered in portal hypertension, and which may give rise to severe 
non-variceal haemorrhage. It accounts for bleeding in about 5-8% of cirrhotics. The bleeding 
is diffuse and may be slow, presenting with anaemia or severe. Pharmacological treatment or 
if necessary TIPSS or surgery are indicated for control of bleeding. 
Orthotopic liver transplantation should be considered in any patients with cirrhosis and 
variceal bleeding. Should prior shunt surgery be necessary for control of bleeding, TIPSS 
should be employed rather than a surgical portal systemic shunt as the latter, by disturbing 
the venous anatomy and by causing adhesions and tissue distortion, render later 
transplantation hazardous. 
Hepatic encephalopathy 
In cirrhosis, acute encephalopathy is usually associated with one or more precipitating 
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factors such as. gastrointestinal bleeding, infection, over-diuresis, inappropriate sedation, a 
high-protein meal, renal failure, hypokalaemia, severe alkalosis, an alcohol binge, portal 
systemic shunting, worsening hepatic damage and the development of hepatoma. However, 
patients may have recurrent episodes of hepatic encephalopathy without any precipitating 
factors; this is termed chronic recurrent encephalopathy. Patients may also develop 
irreversible neurological deficits, known as chronic persistent encephalopathy or 
hepatocerebral degeneration (Cordoba & Blei 1997). 
The most frequent neurological disturbance in cirrhosis is a mild cognitive impairment which 
may only be detected on psychometric testing. This is termed subclinical encephalopathy 
and may be present in 50-70% of all patients with cirrhosis. 
Different mechanisms have been proposed for the development of hepatic encephalopathy. 
They include the following: 
1. Ammonia hypothesis. There is accumulation of unmetabolised ammonia because of 
poor hepatic function and portal systemic shunting. 
2. False neurotransmitter hypothesis. Aromatic amino acids (phenylalanine, tyrosine and 
tryptophan) increase at the expense of branched-chain amino acids (leucine, isoleucine 
and valine) with a reversal of the normal ratio. This is postulated to lead to the production 
of false neurotransmitters that may promote hepatic encephalopathy. 
3. Gamma-amino butyric acid (GABA) hypothesis. There is an increase in the 
concentration of benzodiazepine-like substances that bind to the benzodiazepine-binding 
site of the GABA receptor and enhance its inhibitory action. 
4. Other hypotheses include a reduction in the concentration of enzymes required for the 
urea cycle owing to zinc deficiency, and deposition of manganese in the basal ganglia. 
Treatment that is of proven efficacy for hepatic encephalopathy is based on the ammonia 
hypothesis; there are other experimental treatments based on some of the other hypotheses. 
Treatment of encephalopathy 
Acute encephalopathy 
This is usually associated with a precipitating factor but occasionally may develop 
spontaneously in patients with advanced cirrhosis and large portal systemic shunts. 
Treatment is based on correction of the precipitating factor and dietary protein restriction. 
Protein must not however be restricted unnecessarily and must be reintroduced once the 
patient improves. 
Lactulose (beta galactofructose), a non-absorbable disaccharide, is the treatment of choice. 
It works by removing dietary and endogenous ammonia-producing substances in the 
gastrointestinal tract by its osmotic cathartic action. In addition, lactulose lowers colonic pH 
by the production of organic acids through bacterial fermentation. The decreased pH reduces 
urease-producing intestinal bacteria and thus reduces the production of ammonia in the 
colon . If oral administration or nasogastric tube administration is impossible, lactulose 
enemas may be used. The aim is to produce 2-4 soft, acidic stools per day. In lactose-
intolerant subjects, lactose is as effective as lactulose. 
Neomycin is also effective but is rarely used initially because of its ototoxic and nephrotoxic 
potential. Metronidazole may also be used over short periods as it has activity against urease 
producing organisms but is again associated with significant side-effects. 
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Chronic encephalopathy 
Treatment for chronic encephalopathy is with dietary protein restriction and lactulose. 
Patients with TIPSS, surgical or spontaneous portal systemic shunts are also treated by 
protein restriction and lactulose, but embolisation or surgical ligation of portal systemic 
shunts may be beneficial if encephalopathy is refractory. In TIPSS, refractory 
encephalopathy can sometimes be managed by implanting a reducing stent. 
Most patients will respond to the above measures. Patients who, in spite of these treatments, 
do not improve or develop recurrent encephalopathy need evaluation to exclude other 
disorders resembling encephalopathy or other occult precipitating factors , such as zinc 
deficiency. If no precipitating factors are found, one should search for large, spontaneous 
portal systemic shunts by Doppler ultrasound. If present, one may embolise or surgically 
reduce them (Cordoba & Blei 1997). 
Management of encephalopathy should include evaluation for transplantation in appropriate 
candidates but the decision is difficult in patients with chronic encephalopathy because of the 
possibility of hepatocerebral degeneration with permanent neurological deficits. 
PROGNOSIS 
In 1964, Child and Turcott developed a system which was used to assess the risk of surgery 
in patients with liver disease and which was modified by Pugh et al (1973). This is now 
known as the Child-Pugh classification. This classification has been used for many years in 
the assessment of prognosis in cirrhotic patients. In this classification , five parameters are 
each given 1,2 or 3 points depending on severity and the scores from each variable are 
added together. The patients are divided into 3 strata depending on the score, which will 
range from 5-15. Those who score 5-6 are assigned to Child-Pugh class A, those who score 
7-9 to class B and those who score 10-15 to class C. The classification is reproduced in the 
Table 1.4. In patients with primary biliary cirrhosis, the level of bil irubin is usually out of 
proportion to other evidence of liver failure so the scoring for bilirubin is different. Hepatic 
encephalopathy in this score is based on the staging of Trey et al (1966) (Table 1.5) . 
This score discriminates well between survivors and non-survivors, and since it is simple, 
easily available and cheap to employ, it has been very useful for prognostication in patients 
with cirrhosis (Infant-Rivard et al 1987). 
When orthotopic liver transplantation became available for the definitive treatment of 
cirrhosis, a number of studies were done to allow for more accurate prognostication and 
therefore timing of liver transplantation in patients with cirrhosis. In these studies, the effects 
of different variables on the prognosis of cirrhosis were studied. In a Spanish study, Gines et 
al found that 42% of patients with compensated cirrhosis remained well-compensated after 
10 years. Female sex, lower age and the absence of stigmata of chronic liver disease, as 
well as lower level of serum gamma globulin and alkaline phosphatase at the time of 
diagnosis were independent predictors of survival in a multivariate analysis (Gines et al 
1987). 
In a study of compensated and decompensated cirrhosis, Italian workers found that in 
compensated patients significant predictors of death were male sex, hepatitis B surface 
antigen positivity, increasing age, prolongation of the prothrombin time and oesophageal 
varices. In decompensated patients, significant indicators of death were hepatocellular 
carcinoma, encephalopathy, haemorrhage, higher AST levels, oesophageal varices, higher 
gamma globulin levels, prolongation of the prothrombin time, continued abuse of alcohol, 
hepatitis B surface antigen positivity, elevated GGT and reduced cholinesterase levels 
(D'Amico et al 1986). 
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Other studies have used different models to predict survival and prognosis of cirrhosis but 
there is no proof that the newer models are better than the Child-Pugh score and they are not 
used in most centres. All studies showed that development of one or more complications 
indicates a substantially worse prognosis in cirrhosis and therefore a decision on 
transplantation should be made as soon as complications are noted. 
Clinical & biochemical measurements 
Encephalopathy (Grade) 
Points scored for increasing 
abnormality 
1 2 3 
None 1 and 2 3 and 4 
Ascites Absent Slight Moderate 
Bilirubin (mg/dl) 1-2 2-3 >3 
Albumin (g/1) >35 28-35 <28 
Prothrombin (seconds prolonged) 1-4 4-6 >6 
For primary biliary cirrhosis bilirubin 1-4 4-10 >10 
(mg/dl 
Table 1.4. Child-Pugh grading of the severity of liver disease 
Stage Mental state Tremor EEG changes 
Stage 1 Euphoria, occasionally Slight Usually absent 
Prodrome (often depression; fluctuant mild 
diagnosed in confusion ; slowness of 
retrospect) mentation and affect; untidy 
slurred speech; disorder in 
rhythm 
Stage 2 Accentuation of stage 1 ; Present (easily Abnormal; 
Impending coma drowsiness; inappropriate elicited) general slowing 
behaviour; ability to maintain 
sphincter control 
Stage 3 Sleeps most of time but Usually present Always 
Stupor reusable; speech incoherent; if patient co- abnormal 
confusion marked operative 
Stage 4 May or may not respond to Usually absent Always 
Deep coma painful stimuli abnormal 
Table 1.5. The staging of hepatic coma 
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CHAPTER 2: DESIGN OF THE STUDY 
INTRODUCTION 
Groote Schuur Hospital (GSH) is a large academic hospital Cape Town. It serves a 
population of about 2 million, comprising three population groups, black people of African 
origin, coloured, who are people of Asian or mixed origin, and white - of European descent. 
The hospital serves as a secondary referral centre for the surrounding regions, as a tertiary 
referral centre for the Western Cape province and much of the Eastern Cape province, and 
as a quaternary super-specialist centre for certain services, including liver and cardiac 
transplantation, for much of South Africa. 
A significant number of patients with cirrhosis present for the first time at Groote Schuur 
Hospital with decompensation and a diagnosis of cirrhosis is made on the basis of 
association of signs of liver failure , portal hypertension, radiological features consistent with 
cirrhosis with or without a proven cause of cirrhosis (personal observation). A study in Italy 
and another study done in Birmingham showed that a proportion of 63% and 65% 
respectively of patients have decompensated cirrhosis when first seen and in the English 
study the figure was unchanged in 18 years (Saunders et al 1981, D'Amico et al 1986). 
Most patients with cirrhosis remain compensated for many years and have a relatively long 
life expectancy. Clinical decompensation, which is evidenced by the development of one or 
more complications, has a poor prognosis. The high rate of repeated consultations in 
patients with cirrhosis confirmed the high morbidity associated with this condition (Dufour et 
al 1993). In the United States between 1973 and 1983, cirrhosis mortality declined by one 
third to 10.2/100 000 deaths and the decline continued through to 1987 when the death rate 
reduced to 9.2/100 000 deaths. Furthermore, an increase in morbidity was observed with this 
decreasing mortality rate (Noble et al 1993). 
AIM OF THE STUDY 
Accordingly, this study was intended to delineate the demographic and clinical profile of 
patients with cirrhosis admitted to our hospital, to assess the relative importance of the 
various underlying causes of cirrhosis, to assess the frequency of complications of cirrhosis 
and describe their presentation and management, to assess the outcome of treatment and to 
estimate its cost. 
METHODS 
Patients 
All patients admitted to Groote Schuur Hospital have their diagnoses coded according to the 
International Classification of Diseases No. 9 (ICD-9); these are captured on computer. A 
sample of those patients with a computer-coded diagnosis of cirrhosis, which is under code 
571, were retrospectively studied. Names of patients with the codes indicated in Table 2.1 
were retrieved from the hospital computer system. Patients with the code for chronic hepatitis 
(code 571,4) were not eligible for this study and were not retrieved . 
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571 Chronic liver disease and cirrhosis 
571 .0 Alcoholic fatty liver 
571 .1 Acute alcoholic hepatitis 
571 .2 Alcoholic cirrhosis of liver 
571 .3 Alcoholic liver damage, unspecified 
571 .5 Cirrhosis of liver without mention of alcohol 
571 .6 Biliary cirrhosis 
571 .8 Other chronic non-alcoholic liver disease 
571 .9 Unspecified chron ic liver disease without mention of 
alcohol 
Table2.1. ICD-9 classification categories used for preliminary search for eligible subjects. 
Inclusion criteria 
Patients were eligible for study if they fulfilled the following criteria: 
• Review of the hospital folder confirmed that the diagnosis of cirrhosis was correct 
• They had been admitted for a period exceeding 24 hours on at least one occasion during 
the period 1/1/1993 and 31/12/1996. 
Exclusion criteria 
Patients were excluded for the following reasons: 
• They carried a diagnosis of alcoholic fatty liver, acute alcoholic liver disease, alcoholic 
hepatitis, cholangitis, portal hypertension, or congenital hepatic fibrosis with no evidence 
of cirrhosis. 
• The period of admission was less than 24 hours 
• The hospital records were incomplete 
• Patients admitted solely for the purpose of immediate transplantation were excluded as 
they represent a highly selected group. 
Subjects 
413 candidates carrying the ICD-9 tags listed above were returned by the hospital computer 
system in random order. Of these, the first 98 folders were drawn and inspected further. The 
diagnosis of cirrhosis was confirmed by review of clinical and laboratory data, and all 
admissions between 1 January 1993 and 31 December 1996 were studied. Of the 98 folders 
drawn, 13 were excluded for the following reasons: 
• The folders of 2 patients with apparent cirrhosis contained no data for the period of their 
admissions 
• 11 patients were excluded because a diagnosis of cirrhosis was not substantiated; the 
contributory diagnoses were congenital hepatic fibrosis (2), portal fibrosis (2), tuberculous 
peritonitis, chronic suppurative lung disease, porphyria cutanea tarda, Korsakoff amnestic 
syndrome, severe cardiac failure, myelodysplastic syndrome and acute hepatitis B. 
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Thus, 85 of 98 folders (87%) surveyed fulfilled the inclusion criteria. Assuming, as seems 
reasonable, that the 98 folders were representative of the entire 413 patients returned by the 
hospital computer, we may deduce that the total population of patients with cirrhosis who 
were admitted to GSH during the study period would be approximately 358 patients (87% of 
413 records). 
These 85 folders, as a pilot sample of all those admitted, were then studied in detail. 
RECORDING AND ANALYSIS OF DATA 
The study set out to record all relevant data in terms of demography, diagnosis, how the 
diagnosis was made, severity, biochemical and haematological profiles, the presence of 
complications, utilisation of investigations and specific interventions such as surgery or 
endoscopy, and outcome. The following data were extracted from the folders by the author of 
this dissertation and recorded on a proforma sheet. The data were then captured on a 
personal computer in a custom-designed dBaselV database (Borland International Inc, 
Scotts Valley, USA). 
Data were analysed on a personal computer using Microsoft Access and Microsoft Excel 
(Microsoft Corporation, Seattle, USA); statistical calculations were made with the Statistica 
98 edition software package (StatSoft Inc, Tulsa, USA). The graphs which appear below 
were prepared using Statistica or Microsoft Ecel 97 as appropriate. 
Nature of the data recorded 
Demography: 
a) Name of patient and folder number 
b) Age, sex and race. 
Basis on which diagnosis was established: 




Cause of cirrhosis: 
More than one answer is possible 
a) Alcohol 
b) Iron overload 
c) Hepatitis C virus 
d) Hepatitis B virus 
e) Primary biliary cirrhosis 




Principal reasons for admission: 
More than one answer is possible 
a) Investigation/diagnosis 




e) Gastrointestinal haemorrhage 
f) Other haemorrhage 
g) Spontaneous bacterial peritonitis 
h) Other infection 
i) Renal failure 
j) Hepatoma 
k) Other problems 
Investigations: 
a) Liver function tests: total protein, albumin, globulin, bilirubin, aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), 
gamma glutamyl transpeptidase (GGT) 
b) Electrolytes: - sodium, potassium, urea and creatinine 
c) Alpha fetoprotein (AFP) 
d) Haematological parameters: - haemoglobin (Hb ), white cell count (WCC), platelet 
count, mean corpuscular volume (MCV) and international normalised ratio (INR) 
e) Microbiological results: - blood culture, ascitic white cell count, , ascitic fluid culture, 
Other investigations and procedures: 
a) Chest x-rays 
b) Ultrasound scans 
c) Computerised tomography (CT) scans 
d) Magnetic resonance imaging (MRI) 
e) Endoscopic retrograde cholangiopancreatography (ERCP) 
f) Endoscopy 
g) Variceal injections 
h) Paracentesis 
i) Laparotomy 
j) Any other procedures 
Problems arising during hospital stay: 
a) Ascites 
b) Encephalopathy 
c) Gastrointestinal haemorrhage 
d) Other bleeding 
e) Spontaneous bacterial peritonitis (SBP) 
f) Other infection 
g) Renal failure 
h) Hepatoma 
i) Alcohol withdrawal 
j) Confusion not due to encephalopathy 
k) Temperature 
I) Other problems 
Course and outcome 
a) Number of admissions between 1 January 1993 and 31 December 1996 
b) Number of days in hospital and number of days in intensive care unit (ICU) 
c) Whether died during the admission or discharged 




85 patients were reviewed. There were 57 coloured patients, 14 black patients and 14 white 
patients, comprising 67.1 %, 16.5% and 16.5% respectively. The percentage contribution of 
each group is shown in Table 3.1 and is compared with percentages of the hospital as a 
whole and for the Western Cape. The hospital figures are derived from hospital records for 
1995, kept by the Medical Informatics Unit of Groote Schuur Hospital, and the population 
figures for the Western Cape from the 1996 census. 
This study GSH profile W Cape profile 
Black 16.5 28 20.9 
Coloured 67.1 62 54.2 
White 16.5 10 20.8 
Table 3.1. Distribution of patients by population group, compared with the distributions in the 
GSH patient population and in the Western Cape. 
Gender and age 
49 patients were male (57.6%) and 36 were female (42.4%) with a male-to-female ratio of 
1.36:1 . There is no significant difference in the mean age according to sex but the distribution 
of age at admission is different for male and female patients as shown in Table 3.2 and 
Figure 3.1. Male admissions peak between 40 and 70 years but are more evenly distributed 
between the ages of 30 and 90 years in female patients. The mean ages according to race 
are shown in Table 3.3. The mean age of white patients is significantly higher than that of 
coloured patients (p=0.009 student t test); the difference between white and black patients 
did not reach statistical significance, probably because of the small sample size. 
Mean age ±SD Range 
All patients 55.5±14.5 15 - 87 
Females 57.0±18.5 15 - 87 
Males 54.4±10.8 25 - 78 
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Figure 3.1. Age on admission by sex 
n Age 
Black 14 58.5±11.8 (39-79) 
Coloured 57 53.2±14.6 (15-86) 
White 14 60.5±15.3 (25-87) 
Table 3.3 Age distribution by race. 
DIAGNOSIS OF CIRRHOSIS 
A diagnosis of cirrhosis was confirmed histologically on liver biopsy in 30 of the 85 patients 
(35%). In the remainder, the diagnosis was presumed on the basis of a typical clinical 
appearance; in some cases, ultrasound or CT scanning had been suggestive. Of the 68 
patients with alcoholic cirrhosis, 19 or 27.9% had had liver biopsies performed whereas of 17 
patients with no history of alcohol, 11 (65%) had had liver biopsies. Of the 12 patients with 
both alcoholic cirrhosis and viral infection, only 1 patient (8%) had had a liver biopsy 
performed. 
AETIOLOGY OF CIRRHOSIS 
Cirrhosis was classified as viral if hepatitis B surface antigen was positive and/or hepatitis C 
virus antibodies were positive. Only 3 patients had hepatitis C viral PCR for RNA done, of 
which 1 was negative whilst the antibodies were positive. This patient was counted as 
hepatitis C virus negative. The presumed causes of cirrhosis are shown in Table 3.4 below. 
Table 3.5 shows the aetiology of cirrhosis according to gender and race. Table 3.6 shows the 
proportion of patients according to race in whom viral infection played a role in the aetiology 
of cirrhosis. 
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71.4% of males had alcoholic cirrhosis compared to 58.3% of females ; the difference is 
significant (p=0.002, based on Pearson's x\ The male-to-female ratio for alcoholic cirrhosis 
is 1.7:1; for viral cirrhosis it is 2:1, whilst for other causes of cirrhosis it is 1:4.5. Viruses co-
existed with alcohol in 20.4% of the males. 
Four males (8.2%) with no history of alcohol had the following causes of cirrhosis: hepatitis B 
virus, hepatitis C virus, congenital and cryptogenic cirrhosis. 
Cause Male Female Total 
Alcohol alone 35 21 56 
Alcohol with HBV 3 0 3 
Alcohol with HCV 5 1 6 
Alcohol with HBV and HCV 2 1 3 
All alcohol (with or without 45 23 68 
viral infection) 
HBV alone 1 1 2 
HCValone 1 3 4 
HBVwith HCV 0 0 0 
All HBV or HCV (with or 12 6 18 
without alcohol) 
Iron overload 0 1 1 
Cryptogenic 1 3 4 
Autoimmune 0 1 1 
Biliary stricture 0 1 1 
PBC 0 2 2 
Congenital 1 1 2 
Neither viral nor alcohol 2 9 11 
Table 3.4. Aetiology of cirrhosis in 85 patients. 
Black Coloured White 
Sex M F Total M F Total M F Total 
Alcohol 6 3 9 (64%) 24 13 37 4 5 9 (64%) 
(63%) 
Alcohol+virus 3 0 3 (21%) 5 2 7 (12%) 1 0 1 (7%) 
Virus alone 1 0 1 (7%) 1 3 4 (7%) 0 1 1 (7%) 
Other 1 0 1 (7%) 3 6 9 (16%) 2 1 3 (21 %) 
Total 11 3 14 33 24 57 7 7 14 
Table 3.5. Aetiology of cirrhosis according to gender and race. M: Male; F: female. 
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Black Coloured White 
HBValone 2 (14.3%) 1 (1.8%) 0 (0%) 
HCValone 1 (7.2%) 7 (12.3%) 1 (7.2%) 
Both HBV and HCV 3 (21.4%) 3 (5.3%) 0 (0%) 
Total 6 (42.9%) 11 (19.3%) 1 (7.2%) 
Table 3.6. Distribution of viral infection. 
Figure 3.2 suggests that patients with a combination of alcoholic and viral liver disease 
present at a younger age than those with alcohol alone who in turn present younger than 
those with viral infection alone; Fig 3.2b however shows that this is in fact to the rather 
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Figure 3.2. The median age on admission is dependent on the diagnosis; and is lower in 
alcohol-associated cirrhosis than in viral cirrhosis, and is earlier still where both are 
present (2a). However, subgroup analysis suggests that HBV-associated cirrhosis (with 
or without associated alcohol) presents earlier than alcoholic cirrhosis alone; HCV-
associated cirrhosis (with or without alcohol) presents later than alcoholic cirrhosis 
alone (2b). 
Thirteen females (36.1 %) had no history of alcohol, and the causes of cirrhosis listed were 
hepatitis B virus, hepatitis C virus (3 patients) , iron overload, autoimmune, cryptogenic (3 
patients), primary biliary cirrhosis (2 patients), biliary stricture and congenital cirrhosis. 
For the whole group of 85 patients, alcohol alone accounts for 56 cases of cirrhosis 
(65.8%). Viruses account for 18 patients with cirrhosis (21 .2%) including 12 in whom there 
is alcohol involvement as well. Viruses are thus involved in 21 .2% of patients with cirrhosis. 
Viral infection played a role in 43% of black patients, 19% of coloured patients and 7% of 
white patients. 
PRINCIPAL REASONS FOR ADMISSION 
Patients with cirrhosis are commonly admitted to hospital because of decompensation with 
evidence of one or more major complications of cirrhosis. Occasionally they are admitted 
electively for investigation only or assessment for liver transplantation and sometimes for an 
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unrelated problem. The number of admissions over the 4-year period is shown in Table 3.7. 
There is no significant difference in the number of admissions by gender or by race. Table 
3.8 shows the principal reasons for admission ranked in the order of frequency. The five 
most frequent reasons for admission are GIT haemorrhage (31.5%), encephalopathy 
(27.6%), ascites (24.6%), infections (16.3%) and for investigation (14.8%). Figure 3.3 
indicates that patients who suffered gastrointestinal haemorrhage were more likely to require 
repeated admissions than those who did not. 
No. admissions Mean ± standard Range 
deviation 
All patients 3.6±2.0 1 - 8 
Female 3.9±2.4 1 - 8 
Male 3.3±1 .7 1 - 7 
Black 3.4±1 .5 1 - 5 
Coloured 3.5±2 1 - 7 
White 4±2.3 1 - 8 
Table 3.7. Number of admissions by gender and race over the four-year period. 
GIT haemorrhage 64 (31 .5%) Dehydration 6 (3.0%) 
Encephalopathy 56 (27.6%) Hernia repair 6 (3 .0%) 
Ascites 50 (24.6%) Other haemorrhage 6 (3.0%) 
Infections other than SBP 33 (16.3%) Heart failure 5 (2.5%) 
For investigation 30 (14.8%) Stroke 4 (2.0%) 
Acute alcoholic hepatitis 11 (5.4%) Transplant assessment 2 (1 .0%) 
SBP 8 (3.9%) Hepatoma 2 (1 .0%) 
Renal failure 7 (3.4%) 
Subtotals 
All haemorrhage 70 (34.5%) All infections 41 (20.2%) 
Table 3.8. Principal reasons for admission. 
LABORATORY VALUES 
Biochemical results 
Tables 3.9 and 3.10 show the biochemical results encountered in these patients. Table 3.9 
reflects the average, minimum and maximum values measured across all admissions; Table 
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GASTROINTESTINAL HAEMORRHAGE 
Fig 3.3. Number of admissions per patient during the period of the study categorised by the 
presence of gastrointestinal haemorrhage at any stage of the study. 
or outside the significant values indicated, at any stage during the period of the study. 
87 .1 % of the patients had an albumin less than 35 and in 70.6% it was less than 30. 90.6% 
had bilirubin more than 17 and in 62.4% it was more than 40, suggesting clinical jaundice. 
AST was raised in 90.6% of patients and was rais d to twice normal value in 70.6% 
compared to ALT, which was raised in 62.4% and raised to twice normal value in only 30.6%. 
More than 50% of patients had alkaline phosphatase (ALP) and gamma glutamyl 
transpeptidase (GGT) more than twice normal. Table 3.11 shows the AST/ALT ratio in 
different causes of cirrhosis. There is a significant difference in the AST/ALT ratio in patients 
with alcoholic cirrhosis with or without viral infection and patients with viral cirrhosis without 
alcohol. It is significantly higher in alcoholic cirrhosis (p=0.018 by ANOVA). 
Variable n Mean±standard Min Max 
deviation 
Total protein 164 72.2±11 .8 32 24 
Albumin 166 28.0±6.7 13.0 48 
Globulin 163 44.3±12.0 11 .0 
Bilirubin 166 95.9±125.1 4.0 
AST 164 100.8±209.7 14.0 
ALT 164 39.9±58.4 5.0 
AST/ALT 
ALP 162 162.9±115.0 51 722.0 
GGT 73 232.2±285.7 12.0 1434.0 
Table 3.9. Biochemical values averaged over all admissions. 
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Fig 3.3. Number of admissions per patient during the period of the study categorised by the 
presence of gastrointestinal haemorrhage at any stage of the study. 
or outside the significant values indicated, at any stage during the period of the study. 
87.1 % of the patients had an albumin less than 35 and in 70.6% it was less than 30. 90.6% 
had bilirubin more than 17 and in 62.4% it was more than 40, suggesting clinical jaundice. 
AST was raised in 90.6% of patients and was raised to twice normal value in 70.6% 
compared to ALT, which was raised in 62.4% and raised to twice normal value in only 30.6%. 
More than 50% of patients had alkaline phosphatase (ALP) and gamma glutamyl 
transpeptidase (GGT) more than twice normal. Table 3.11 shows the AST/ALT ratio in 
different causes of cirrhosis. There is a significant difference in the AST/ALT ratio in patients 
with alcoholic cirrhosis with or without viral infection and patients with viral cirrhosis without 
alcohol. It is significantly higher in alcoholic cirrhosis (p=0.018 by ANOVA). 
Variable n Mean±standard Min Max 
deviation 
Total protein 164 72.2±11.8 32 124 
Albumin 166 28.0±6.7 13.0 48 
Globulin 163 44.3±12.0 11.0 97.0 
Bilirubin 166 95.9±125.1 4 .0 818.0 
AST 164 100.8±209.7 14.0 2160.0 
ALT 164 39.9±58.4 5.0 510.0 
AST/ALT 2.6±1.4 0.3 10.1 
ALP 162 162.9±115.0 51 722.0 
GGT 73 232 .2±285.7 12.0 1434.0 
Table 3.9. Biochemical values averaged over all admissions. 
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Variable Cut-off value n Cut-off Cut-off 
exceeded exceeded% 
Total protein >80 85 26 22.1 
<60 85 17 14.5 
Albumin <35 85 74 87.1 
<30 85 60 70.6 
Bilirubin >17 85 77 90.6 
>40 85 53 62.4 
AST >25 85 77 90.6 
>50 85 60 70.6 
ALT >25 85 53 62.4 
>50 85 26 30.6 
AST/ALT >2 85 57 67.0 
ALP >70 83 79 95.2 
>140 83 43 51 .8 
GGT >50 47 36 76.6 
>100 47 31 66 
Table 3.10. Proportion of patients showing biochemical values outside the normal range or 
beyond some significant levels at any stage of the study. 
Alcohol 2.71 
Alcohol+HBV or HCV 2.49 
HBVor HCV 1.63 
Other 2.50 
Table 3.11. AST/ALT ratios 
Electrolytes 
These are shown in Table 3.12 and 3.13 below. The mean sodium was significantly lower in 
males than in females (p=0.014 Mann-Whitney U test) (Fig 3.4.). There was a trend to a 
lower sodium in alcoholic rather than viral cirrhosis (p=0.08; Mann-Whitney U test) with 
median values of 136 and 139 mmol/1. A correlation of sodium with Child-Pugh score showed 
a highly significant correlation (p<0.001, Pearson Product-Moment correlation), and a 
significant association between hyponatraemia and ascites (p=0.003, Student's t test) . These 
results are discussed further in the following chapter. 
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Variable n Mean (S.D.) Min Max 
Sodium 187 136±5.7 106 146 
Potassium 187 4.1±0.8 2.1 8.2 
Urea 185 7.7±8.2 0.4 74 
Creatinine 187 115±104 44 1019 
Table 3.12. Electrolyte values averaged over all admissions. 
Variable Cut-off n Exceeded % Exceeded% 
Sodium <135 84 39 46.4 
Potassium 
Urea >6.7 84 38 45.2 
Creatinine >115 84 29 34.5 
Table 3.13. Proportion of patients showing electrolyte values outside the normal range or 
beyond some significant levels at any stage of the study. 
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Figure 3.4. Hyponatraemia is correlated with sex. 
Haematological results 
The mean haematological values are shown in Table 3.14; Table 3.15 indicates the 
proportion of our total study population who fell outside the normal range, or outside the 
significant values indicated, at any stage during the period of the study. INR was abnormal in 
74.4% of patients and was more than 2 in 28.8% of patients. Anaemia was present in 78.3% 
of the patients and in 53% of the patients, the haemoglobin was less than 10. 22.9% had 
leucopenia and 56% had a thrombocytopenia of less than 100. The mean cell volume (MCV) 
was raised in 66.3% of patients. 
Table 3.16 shows the white cell count in infected and non-infected patients. Infected patients 
are defined as those in whom the presence of infection as a significant factor was recorded 
in the notes. Figure 3.4a shows the white cell count according to the presence or absence of 
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infection, while Figure 3.4b shows the white cell count categorised by the cause of the 
cirrhosis and suggests that the white cell count is lower in viral cirrhosis than in alcohol-
associated cirrhosis. Figure 3.5 shows the MCV in alcohol and viral cirrhosis and shows that 
this correlates poorly with cause. 
Variable n Mean (SD) Min Max 
INR 152 1.7 ± 0.7 0.9 4.5 
HB 117 10.4 ± 2.8 1.9 17.0 
White cell count 166 8.6 ± 5.6 0.9 31 .2 
Platelets 166 133 ± 88 13 568 
MCV 158 96.9 ± 10.8 66 113 
Table 3.14. Haematological values averaged over all admissions. 
Variable Cut-off n Cut-off Cut-off exceeded 
exceeded % 
INR >1.3 78 58 74.4 
>=2 78 25 25.6 
HB <12 83 65 78.3 
<10 83 44 53 
White cell count >11 83 33 39.8 
<4 83 19 22.9 
Platelets <150 82 61 74.4 
<100 82 46 56 
MCV >94 80 53 66.3 
>=100 80 41 51 .2 
Table 3.15. Proportion of patients showing haematological values outside the normal range or 
beyond some significant levels at any stage of the study. 
Infection n Mean (S.D.) Median Minimum Maximum 
Infection present 44 10.2 (7.0) 8.1 0.9 31 .2 
No infection 122 8.1 (7 .5) 7.0 2.1 30.1 
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Figure 3.5. Influence of the cause of cirrhosis on MCV. 
COMPLICATIONS OF CIRRHOSIS 
Figure 3.6 shows the incidence of complications of cirrhosis present both at the time of 
admission and as an aggregate of those present when admitted as well as those which 
developed subsequently. Only one patient is recorded as having developed SBP subsequent 
to admission; encephalopathy, ascites and renal failure, frequently present when first 
admitted, also developed subsequently in a significnat proprtion of the remainder during the 
course of hospitalisation. 
Temperature 
The mean temperature on admission was 36.6 ± 0.8 with a minimum of 35 and a maximum 
of 39.9. There was, as expected, a significant difference in temperature on admission 
between those patients with infection and those without (p=0.009 ANOVA). There was 
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Figure 3.6. Frequency of complications; either at time of admission or, cumulatively, by 
end of admission. The lower, light bar represents the proportion of admissions in which 
the presence of the complication was already noted on admission; the upper, dark bar 
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Figure 3.7. Influence of presence of infection on temperature. 
Blood cultures 
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Blood cultures were performed in 72 of the 203 admissions of which 10 (13.9%) were 
positive. The organisms grown from the blood cultures are shown in Table 3.17. 
Ascitic fluid white cell count 
The results of ascitic fluid white cell count are shown in Table 3.18. 66 ascitic fluid cultures 
were performed. Four cultures yielded positive results, 1 of which grew Staphylococcus 
epidermidis which was probably a contaminant. The other 3 cultures representing 4.5% of 
the total submitted grew Streptococcus pneumoniae, Eschericha coli and corynebacteria 
species. 
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Proteus mirabilis 1 
Strep. pneumonia 2 
Klebsiella pneumoniae 1 
E. coli 1 
Staph. aureus 1 
Enterobacter 1 
Salmonella species 2 
Staph epidermidis (? contaminant) 1 
Table 3.17. Organisms recovered on blood culture. 
Number submitted 35 
Mean wee (Range) 350 (40-2500) 
Neutrophil count: 
Number reported adequately 19 
Mean (S.D.) 151 (559) 
Range 1-2460 
Number>250 1 
Table 3.18. Analysis of ascitic fluid for wee count. 
OUTCOME AND PROGNOSIS 
28 patients died in hospital while the deaths of a further 13 patients were noted in the folders 
by the time they were reviewed in 1997 yielding 41 patients in total. This translates to a 
mortality of 48.2% over approximately 5 years. The Child-Pugh classification of those 
patients who could have their Child Pugh scores calculated is shown in Table 3.19 with the 
number of admission per patient and the overall mortality for each class. The probability of 
survival according to the Child-Pugh classification is shown in Figure 3.7. 
There was no significant difference between the causes of cirrhosis and the Child-Pugh 
score. A higher Child-Pugh score was associated with a high number of admissions (p=0.04, 
Spearman rank order correlation coefficient) . 
PROCEDURES AND INVESTIGATIONS PERFORMED 
The more common investigations and procedures performed during the course of admission 
are listed in Table 3.20 below. The columns reflect the number and percentage of all 
admissions in which at least one such investigation or procedure was performed. 
COSTS 
Class A Class B Class C 
Patients 8 28 41 
Admissions 18 55 67 
Admissions/patient 1.6 2.1 2.8 
Range 1-4 1-5 1-8 
Average hospital stay 6.5 8.5 9.9 
Range 2-13 2-36 1-33 
Overall mortality 25% 39.3% 63.4% 
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Figure 3.7. Probability of survival categorised by Child-Pugh class. 
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Costs are worked out from figures compiled by the Medical Accounting Process (MAP) office 
at Groote Schuur Hospital, which calculates ward costs for the different units and sub-units at 
GSH. The ward costs include blood, nursing and medical salaries, telephone, transport, 
catering , stationery, medical consumables and pharmacy. Costs of procedures and theatre, 
e.g. endoscopy and variceal injections, and radiological investigations, e.g. X-rays, 
ultrasound and CT scans, are not included. The ward procedures such as abdominal 
paracentesis and lumbar punctures are not separately costed, as they are subsumed within 
the MAP figures applied to each admission. The figures shown represent an underestimation 
since laboratory investigations are separately costed , and some of the investigations listed in 
the table were performed not once, but serially. 
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Procedure Number % Procedure Number % 
Chest X-ray 110 54% Other procedures 15 7% 
Endoscopy 70 34.5% Head CT scan 9 4.4% 
Abdominal 66 33% Abdominal CT scan 8 3.9% 
paracentesis 
Variceal injections 42 21% ERCP 7 3.4% 
Abdominal X-ray 19 9.3% Lumbar punctures 5 2% 
Liver biopsies 18 9% Laparotomies 2 1% 
Ultrasound 16 7.9% 
Table 3.20. Investigations and other procedures performed during admission. The columns 
reflect the number and percentage of all admissions in which at least 1 such investigation or 
procedure was performed. 
The mean length of admission for patients was 7.8 days, range 1-36. Figures compiled by 
the MAP office indicate that the average daily cost per patient in 1998 in a surgical ward was 
R353.00 and in a medical ward R340.00. Assuming that patients with gastrointestinal 
bleeding and hernia were admitted to the surgical area, (mean length of admission 7 days) 
and those with other problems to the medical area (mean length of admission 8.2 days) , 
ward costs in 1998 terms may be estimated according to Table 3.21 . 
The estimated cost of the radiological procedures was supplied by Professor S Beningfield, 
Dept of Radiology, Groote Schuur Hospital and is derived from the South African Medical 
Association's scale of benefits whilst the estimated costs for surgical and endoscopic 
procedures was supplied by Professor J Krige, Dept of Surgery, Groote Schuur Hospital. 
Table 3.22 shows the cost of other investigations and procedures. 
Adding these two figures together suggests a figure of R685 930 as a total estimated cost for 
the in-hospital care of these 85 patients over a period of four years; during these four years 
41 of these 85 patients died. This equates with an estimated cost per patient per year for in-
patient admissions of R2017, with a 12% mortality each year. Conversely, extrapolating to 
the figure of 358 eligible patients whose names were returned by the hospital computer 
system, the estimated cost over this period would be approximately R2.9 million. 
Admissions Average stay Total days Total cost 
Medical 130 8.2 1066 362 440 
Surgical 73 7.0 511 180 383 
Total 203 1577 542 823 
Table 3.21. Estimated total cost for all admissions for cirrhosis in the subjects under study. 
35 
Procedure Cost Total cost 
(Rand) (Rand) 
Abdominal CT scan 904.86 7239 
Abdominal X-ray 59.20 1125 
Chest X-ray 59.20 6512 
Endoscopy and variceal 300.00 100800 1, 
injections I' 
ERCP 371 .50 2600 
Head CT scan 648.78 5839 
Laparotomies 8000.00 16000 
Ultrasound 187.00 2992 
Total 143107 
Table3. 22. Cost of investigations and other procedures performed during admission. 
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CHAPTER 4: DISCUSSION 
DEMOGRAPHIC DATA 
Race 
Compared to their contribution to the patient population of GSH, white patients are over-
represented in this study of cirrhosis (p=0.03, Pearson's x2; Table 3.1 ). There are two likely 
reasons for this discrepancy. Firstly, whereas most white patients in the Western Cape are 
able to afford and therefore attend private medical services, those with chronic disorders 
such as cirrhosis may attend the public sector for financial reasons. Secondly, the Groote 
Schuur Hospital Liver Clinic is a super-specialist unit, offering services, including 
transplantation, which are not available in the private sector. In contrast, black patients are 
under-represented among the cirrhotic population in comparison with their representation in 
the general hospital population (p=0.02 Pearson's x2,). The explanation for this is not 
immediately apparent. It is not generally believed that cirrhosis is any less common among 
black patients than among other patients, but only a population-based study would be able to 
determine whether the incidence of cirrhosis actually varies with race. The number of 
coloured patients with cirrhosis is in direct proportion to their representation amongst the 
general hospital population. 
Of peripheral interest is the observation that, in comparison with their contribution to the 
population of the Western Cape, black patients are over-represented in the general hospital 
population (p=0.000, Pearson's x2); probably because a high proportion are indigent and 
entirely dependent on state health services. Additionally it is generally believed that a 
significant number of black patients domiciled in the Eastern Cape province attend Groote 
Schuur hospital for treatment because of perceived deficiencies within the Eastern Cape 
health care system. 
Sex 
It is apparent that the sex ratio for cirrhosis differs between black patients on the one hand, 
and coloured and white patients on the other (Table 3.5). The overall male-to-female ratio of 
this population is 1.36: 1. The ratio for coloured and white patients are 1.3: 1 and 1: 1 
respectively, which are similar to the 1.3:1 ratio in the study of Seebaran in Indian cirrhotic 
patients in Natal. By contrast, our observed ratio for black patients is 3.6: 1. This is similar to 
the 3: 1 male-to-female ratio found in two studies in black cirrhotic patients (Wicks et al 1977, 
O'Keefe et al 1982). By comparison , the male to female ratio described in western countries 
for cirrhosis is 2: 1. 
The sex-ratio differences between black patients and the coloured and white patients may 
relate to different patterns of drinking in these communities. Culturally, in the black 
community, alcohol intake, particularly of beer and spirits, is discouraged amongst females .. 
Even traditional beer is taken by young females only on special occasions, but is generally 
freely available to older women. However, as a personal observation , there has been an 
increase in ethanol intake in black females in the urban areas in the form of beer, wine, 
aperitifs and liqueurs. In contrast, in the coloured and white communities, it is accepted for 
females to take alcohol , especially wine on social occasions. 
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Gender and age 
In this study, there was a strong clustering of admissions for cirrhosis in males between the 
fourth and seventh decades, with a pronounced peak in the fifth to seventh decades, while 
for females there was a wider spread over the third to the eighth decade (Fig 3.1 ). This may 
be related to the fact that most cirrhosis in our male patients was related to alcohol and might 
therefore be expected to develop after about 20 years of heavy ethanol abuse, followed by a 
further 5-10 years before they decompensate to the point of requiring admission. The causes 
of cirrhosis are more diverse in females and may present earlier, as with autoimmune 
hepatitis, or later, as with primary biliary cirrhosis. 
One of the interesting and significant findings was that the mean age at admission was 
significantly lower for coloured patients than for the other two groups (Table 3.3). This cannot 
be accounted for by a difference in aetiology of the cirrhosis; alcohol accounted for about 
64% in all three groups. A possible explanation for the older age in whites is that younger 
patients with cirrhosis may have less advanced disease, may still be economically active and 
therefore better able to afford private medical care, only requiring state assistance at an older 
age. We are unable however to account for the later presentation of black patients; as such a 
mechanism would not apply. A possibility we considered is that a higher prevalence of viral 
cirrhosis might predispose to variations in age; this is difficult to sustain since both black and 
white patients, with the highest and lowest incidence of viral cirrhosis, had a higher age than 
the coloured patients, with an intermediate level. 
DIAGNOSIS OF CIRRHOSIS 
Because of the importance of giving a patient a prognosis, as well as being able to assess 
the extent of liver disease, all patients presenting clinically with cirrhosis should as far as 
possible have a liver biopsy. This is additionally invaluable in monitoring the progress of liver 
disease and in assessing response to therapy. In alcoholic cirrhosis biopsy is important to 
confirm the diagnosis, to stage liver damage for prognosis and to exclude coexistent 
pathology, such as viral hepatitis or iron overload, as specific treatment may be essential for 
those with a second, potentially remediable cause. Certainly in non-alcoholic cirrhosis, such 
as autoimmune, viral or primary biliary cirrhosis, a biopsy is important to determine the 
cause, to assess the activity in the liver and the extent of the damage and to direct specific 
intervention such as steroid or antiviral therapy (Desmet & Fevery 1995). 
Yet in this study, only 35% of patients had their cirrhosis confirmed histologically. Reports 
suggest that two thirds of cirrhotics are already in a decompensated state when seen for the 
first time and therefore likely to have coagulation problems, ascites and other complications 
which might contra-indicate biopsy (Saunders et al 1981, D'Amico et al 1986). This might be 
one reason for the low biopsy rate in our study. We note that only 2 of 203 admissions were 
electively for transplant assessment; the remainder were largely for crisis management such 
as haemorrhage and infection. Additionally, when clinical signs and radiological features 
suggesting cirrhosis are found with a strong history of ethanol abuse and negative tests for 
other causes of cirrhosis, a clinical diagnosis of alcoholic cirrhosis has often been regarded 
as acceptable. 
The low rate of histologically-proven cirrhosis in our study suggests that biopsy is under-
utilised as a diagnostic tool in our patients. In order to improve the biopsy rate in patients with 
cirrhosis, we would recommend that all patients, irrespective of how they first come to 
medical attention, should be evaluated at least once by a hepatologist or a physician with 
expertise in the management of liver disease, and that patients suspected of having cirrhosis 
should be assessed and biopsied early in their course, before they decompensate to the 
point where biopsy becomes dangerous. Where relative contraindications to percutaneous 
biopsy exist, consideration should be given to the use of transjugular biopsy or plugged 
percutaneous biopsy. 
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AETIOLOGY OF CIRRHOSIS 
Alcohol 
The major cause of cirrhosis in our patients is alcohol. In this series, alcoholic cirrhosis 
accounts for 56 patients (65,8%) (Tables 3.4, 3.5). This is similar to the incidence of alcoholic 
cirrhosis in West Birmingham of 66.4% (Saunders et al 1981 ). In our patients the male-to-
female ratio of patients with alcoholic cirrhosis was 1,7:1, which is somewhat lower than the 
ratio found in western countries, quoted as 2:1 to 4:1 (Friedman et al 1992). 
How reliably were our patients correctly identified as having alcoholic cirrhosis, particularly as 
the biopsy rate was low? Patients labelled as alcoholic cirrhosis in this study are those in 
whom there was a history of heavy alcohol use and in whom no other cause was 
demonstrated; where both a history of alcohol use and evidence of viral infection were 
present, these were recorded separately. However, this diagnostic categorisation was by no 
means rigorous. There was no quantitation of the alcohol intake, the duration of alcohol 
intake, nor of the pattern of exposure - continual versus binge drinking - all of which are 
known to influence the rate of development of cirrhosis in drinkers. The descriptive terms 
used in the hospital notes suggestive of excessive alcohol intake were "history of alcohol 
abuse" or "alcohol bingeing over weekends" and similar non-specific terms. This may have 
resulted in an overestimation of alcoholic cirrhosis in our study. It is also possible that other 
causes of cirrhosis were underestimated as a result of incomplete diagnostic workup, such 
as failure to request and record ferritin estimations, auto-antibodies, hepatitis C viral markers 
and, indeed, biopsies in every patient; especially where the admitting doctor believed that 
alcohol to be the most probable cause. This was due in part to the high proportion of patients 
who presented with major complications for the first time; a considered diagnostic protocol 
may be lost in the urgent necessity to control the acute complications; frequently a surgeon 
rather than a physician was caring for the patient. 
Viral hepatitis 
Viral infections frequently co-existed with excessive alcohol use (Tables 3.4, 3.5). 2.6% of 
our patients are classified as both alcohol and hepatitis B, 5.2% as alcohol and hepatitis C 
and 2.6% as alcohol and both hepatitis B and C. The figures in males were twice that at 
6, 1 %, 10,2% and 4, 1 % respectively. · 
Viral infection was overwhelmingly more common in black than in white patients, with an 
intermediate prevalence in coloured patients. Indeed, hepatitis B infection was present in 
35. 7% of our black patients, compared with 7.1 % and 0% of the coloured and white patients. 
The prevalence of seropositivity for hepatitis B surface antigen is estimated at 4-5% in 
healthy black blood donors in South Africa and less than 0.1 % in white blood donors ( (Bird & 
Gibbs 1994 ); a population survey in black people living in the Western and Eastern Cape 
suggested an HBs antigen carrier rate of 4.3% (Tucker et al 1996). A figure of 4% for the 
coloured population of the Western Cape has been suggested (Tucker T, personal 
communication). It is unclear why hepatitis B is represented at seven times the frequency 
amongst black patients with cirrhosis compared with coloured patients (p=0.004, by means of 
Fisher's x\ despite an equivalent rate of carriage of hepatitis B in their populations and an 
equivalent rate of alcohol use. It is possible that the difference is artefactual; were alcoholic 
cirrhosis more common in coloured than in black patients, a correspondingly smaller 
percentage would be reflected as due to viral infection. Ethnic-dependent differences in viral 
pathogenicity would also offer an explanation, but have not been shown. Though vertical 
transmission of HBV is known to correlate with a more rapid progression to cirrhosis, the 
evidence suggests that transmission in South Africa is largely horizontal, and does not differ 
with race. Nor are the figures biased by a presentation with early hepatoma, as only two 
hepatomas, were recorded in patients with cirrhosis; both were related to hepatitis C viral 
infection - not hepatitis B; the patients were a black and a coloured male respectively. During 
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the study period, other patients were assuredly admitted with hepatoma, yet were obviously 
not classified as having cirrhosis as they are not reflected in this study. This in fact is in 
accordance with our clinical experience; though we occasionally see hepatomas develop in 
patients known to have hepatitis C, most hepatomas in association with HBV develop so 
rapidly that they are diagnosed in patients who have not previously been recognised to be 
either cirrhotic or indeed HBV positive. 
Local figures for the prevalence of HCV are 1,8% in the black population (Tucker et al 1996) 
and less than 1 % in the coloured and white populations (Tucker T, personal communication). 
A strong correlation with cirrhosis is shown in this study, as also a suggestion that co-
infection and concurrent alcohol use are present in many patients. Though hepatitis C 
appears more common in black and coloured cirrhotics than in whites, despite a similar 
background rate in the population, the difference is not significant (p=0.3, by means of 
Fisher's x\ 
Our results suggest that patients with viral cirrhosis present later than those with alcoholic 
cirrhosis (Figure 3.2a). However, on closer inspection, we find that patients with hepatitis B 
present younger than those with alcohol, hepatitis C at an older age (Figure 3.2b ). This is as 
expected: hepatitis C viral infection is known to be an indolent process with a slow 
progression to cirrhosis; the progression is more rapid with hepatitis B. Though numbers are 
small, our results suggest, as seems reasonable, that the combination of both viruses, or 
either virus with alcohol, is associated with a more rapid progression. 
Other causes of cirrhosis 
There were too few patients with causes of cirrhosis other than alcohol or viral to perform any 
further analysis. 
Recommendations 
In order to improve the certainty of the diagnosis in patients with cirrhosis, we would, 
recommend the following steps. All patients should be subjected to a screening programme 
for those aetiological factors which are prevalent in a particular area or population, as is 
outlined below. 
In our patients, the minimum screening would include: 
For alcoholic liver disease 
• An accurate history of alcohol intake, including qualitative and quantitative description 
should be formally recorded on every patient 
For drug-related liver disease 
• An accurate history of drug therapy 
For viral cirrhosis 
• Hepatitis B viral markers 
• Hepatitis C antibodies, followed by polymerase chain reaction (PCR) for viral RNA 
detection in those who test positive, in order to eliminate false positives 
For autoimmune disease, including primary biliary cirrhosis 
• Autoimmune markers: particularly anti-nuclear antibodies (ANA), anti-smooth muscle, 
anti-liver-kidney-microsome (LKM1) and antimitochondrial antibodies 
For haemochromatosis 
• Ferritin levels and transferrin saturation 
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Where appropriate, the following should be performed: 
For biliary tract disease 
• ultrasound 
• cholangiography 
For Wilson's disease 
• Caeruloplasmin, urinary and serum copper estimations and corneal slit-lamp 
examination for Kayser-Fleischer rings 
For alpha-1 antitrypsin deficiency 
• Alpha-1 antitrypsin estimation 
For non-alcoholic steatohepatitis 
• Serum lipid profile and plasma glucose or oral glucose tolerance test 
• must be used to confirm the presence of hepatitis C in those patients with positive 
antibodies 
For other, rarer diseases 
• The appropriate tests. 
And, whenever possible 
• Ultrasound 
• Liver biopsy with an expert opinion 
In every case it is essential that the information is not only sought and tests requested , but 
that the results are adequately recorded. 
REASONS FOR ADMISSION 
There were overlapping reasons for admission and some patients were admitted with two or 
more complications, such as gastrointestinal bleeding and encephalopathy or 
encephalopathy, ascites and infection (Table 3.8). Although ascites is the commonest of the 
major complications of cirrhosis (Runyon 1997), it was not the most frequent reason for 
admission in our patients, probably because ascites can often be controlled on an outpatient 
basis, as is the policy of the Liver Clinic at Groote Schuur Hospital. 
Gastrointestinal haemorrhage 
The most common reason for admission in our patients was gastrointestinal haemorrhage, 
the most serious complication of cirrhosis with a high mortality rate (Stanley & Hayes 1997). 
There are a number of reasons why haemorrhage should be the most common reason for 
admission. Firstly, gastrointestinal bleeding is said to be more frequent in alcoholic than in 
other forms of cirrhosis 55% of our patients were alcoholic and therefore at particular risk of 
haemorrhage. Secondly, patients who have had one haemorrhage are at higher risk of 
bleeding in the future (Stanley & Hayes 1997), and thus more likely to be readmitted , a 
finding confirmed in our study (Fig 3.3). Not reflected in this graph are most of those patients 
who returned for elective sclerotherapy only, or for minor haemorrhage. They are admitted 
overnight only and are not captured in this study, which excluded patients staying in hospital 
for less than 24 hours. It is therefore likely that most of the repeated readmissions reflected 
in Fig 3.3 would have been for further acute complications. 
It is unlikely that any of the patients in our study received either primary or secondary 
pharmacoprophylaxis with beta-blockers or isosorbide for variceal bleeding as these forms of 
treatment were not implemented at Groote Schuur Hospital until later. Primary prophylaxis 
reduces the risk of bleeding by 45%; applied to our study population, admissions for GIT 
bleeding might have been significantly reduced. 
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Encephalopathy 
Since most patients with low-grade encephalopathy can be treated as out-patients with 
lactulose and protein restriction, they are seldom admitted for this reason alone, as indicated 
in this study, where only one of 56 patients with encephalopathy on admission was not 
recorded as having an additional problem necessitating admission; Severe hepatic 
encephalopathy is usually precipitated by one or more factors which may themselves be 
indications for admission. In our study, encephalopathy on admission was almost always part 
of a more severe spectrum of presenting problems; alone or in combination, we recorded 
ascites (15) gastrointestinal bleeding (8), infections including SBP (14), other problems (10) 
and renal failure (6) in association with encephalopathy. It therefore appears that 
encephalopathy is but rarely a reason for admission itself, but is usually a consequence of 
another adverse factor or indeed, serves as a marker of severe decompensation. 
Ascites 
Uncomplicated ascites may be controlled by salt restriction and diuretics on an outpatient 
basis, and treatment is successful in about 90% of patients. Patients with refractory ascites 
or ascites complicated by spontaneous bacterial peritonitis, or ascites in association with 
other complications of cirrhosis need in-patient management. 
Patients with significant ascites should undergo paracentesis for ascitic fluid analysis at their 
first presentation. In general, however, admission will be required for resistant ascites 
requiring multiple paracenteses, for ascites complicated by infection, encephalopathy or 
renal failure, and where ascites is merely one aspect of a decompensating cirrhosis. Of the 
fifty admissions in this study in which ascites was felt to be a significant reason for the 
admission, 17 were admitted for control of ascites only; most of these were recorded as 
having received paracentesis. The other 33 all had other problems necessitating admission 
in addition; including 11 complicated by SBP or other infections. Ascites however frequently 
coexisted with encephalopathy; 15 admissions were necessitated by the combination. 
Infections, including SBP 
Infection, including SBP, accounted wholly or partly for 20.2% of all admissions, confirming 
that infection is a major hazard in patients with cirrhosis. The problem of infection in cirrhosis 
is discussed in more detail later. Only 8 admissions were recorded as having SBP as a major 
reason for admission; the literature suggests a figure of 7-23% (Navasa 1997), and we 
suspect that SBP may have been missed in a significant number of our cases. This is 
discussed later. 
Renal failure 
Renal failure was in fact an uncommon cause for admission, being present in seven 
admissions. Only one of these was recorded as having "problematic" ascites on admission 
despite a known association between ascites (and its treatment) and hepatorenal syndrome. 
It is possible that renal failure may have developed as a result of over-vigorous and too 
successful diuresis with consequent dehydration in these patients; however, all were very ill 
- five had evidence of infection, six were encephalopathic - suggesting that renal failure may 
have resulted from intercurrent acute illness or end-stage disease. Indeed, three of these 
patients died during the same admission, and one died subsequently. 
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LABORATORY FINDINGS 
Albumin, bilirubin and aminotransferases 
A low albumin reflects decreased liver synthetic function (and is a marker of poor hepatic 
function); the decrease is also related to malnutrition associated with cirrhosis, and 
contributes to oedema and ascites formation. In this study, 87% of patients had a reduced 
serum albumin, and in 70.6% it was less than 30, confirming the self-evident fact that it is 
largely patients with advanced cirrhosis who require hospitalisation (Table 3.10). The mean 
globulin concentration exceeded the albumin, demonstrating the classic reversed albumin-
globulin ratio which is secondary to increased antibody production resulting from bypassing 
of the liver as a result of portal systemic shunting, poor hepatic synthetic function, loss of 
Kupffer cells and other mechanisms. 
Typically, patients with compensated cirrhosis may demonstrate normal bilirubin and 
aminotransferases. The high proportion of patients in this study with abnormal values - over 
90% had hyperbilirubinaemia and an elevated AST - reflects the high proportion of severe 
and decompensated cirrhosis seen in this in-patient population. 
AST/ALT ratio 
An AST/ALT ratio exceeding 2 is said to be a sensitive indicator of alcohol-associated liver 
disease. The disproportionately raised AST in alcoholic liver diseases may be due to the 
preferential release of mitochondrial AST or may reflect the zonal distribution of these 
enzymes within the liver acinus. AST is a mitochondrial and cytosolic enzyme which is 
distributed throughout the liver acinus whilst ALT is a cytosolic enzyme located 
predominantly within the periportal zone. With alcohol, it is predominately the mitochondria, 
and the centriacinar zone (zone 3) which are affected. In other forms of liver disease 
associated with hepatocellular damage, ALT is usually raised proportionately more than AST. 
However, values of more than 2 are also seen in other forms of cirrhosis. A rising AST/ALT 
ratio in patients with viral hepatitis and primary biliary cirrhosis suggests the onset of 
cirrhosis. 
An AST/ALT ratio greater than 2 was seen in 67% of our patients, which correlates well with 
an estimated incidence of 64% of alcoholic cirrhosis amongst our cirrhotic patients 
{Table 3.11 ). However, use of the AST/ALT ratio as a predictor of alcoholic cirrhosis in our 
patients had a sensitivity of 77.3%, specificity of 68.4%, positive predictive value (PPV) of 
89.5% and negative predictive value (NPV) of 46.4%, in keeping with the rather poor 
discriminatory ability of this test in advanced cirrhosis of any sort. 
Sodium 
The plasma sodium was significantly lower in males than in females (Fig 3.4), and there was 
a trend to a lower sodium in alcoholic versus non-alcoholic disease. This may account in part 
for the sex difference since alcoholic cirrhosis was more common in males. Factors which 
may have contributed to a lower sodium in alcoholic liver disease include a greater severity 
of cirrhosis or more severe secondary hyperaldosteronism in association with ascites. 
However in this study we were unable to show a higher rate of ascites in alcoholics than in 
viral cirrhosis (34% vs 46%). Therefore the difference in sodium cannot relate to the 
presence or absence of ascites alone. Certainly, in this study, there was a strong correlation 
between hyponatraemia and severity of cirrhosis as measured by the Child-Pugh score, as 
well as between hyponatraemia and ascites. This may be due to secondary 
hyperaldosteronism, the effects of diuretics and salt restriction, and, again, increasing 
severity of cirrhosis. 
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Macrocytosis 
A macrocytosis is often associated with alcohol abuse and may relate both to folate 
deficiency and to a direct effect of alcohol on the bone marrow. It is however also a feature of 
liver disease per se. The MCV exceeded 94 in 66.3% of our patients and exceeded 100 in 
51 .2% (Table 3.15, Fig 3.5). This is consistent with alcohol intake as well as chronic liver 
disease. There was no difference in alcoholic and non-alcoholic cirrhosis in MCV, and 
macrocytosis serves as a very poor predictor of alcoholic disease with advanced cirrhosis. 
Using a cut-off value of 94fl, the sensitivity for alcoholic disease was 71.4%, the specificity 
52.9%, the PPV 84.9% and the NPV, 33.3%. Using a cut-off of 1 OOfl, the values were 57.1 %, 
70.6%, 87.8% and 30.8%. This is insufficiently accurate for any meaningful place in 
diagnosis. 
White cell count 
In cirrhotics a low white cell count is not infrequently found in the presence of infection, 
presumably the result of immunoparesis and of hypersplenism. Although the white cell count 
was higher in patients with infection than those without, there was a large overlap (Fig 3.4a) 
and, in infected subjects, the median value was only 8.1, which is within the normal range. 
Indeed, using a white cell count of 11 as a predictor of infection yields a sensitivity of 31.8%, 
specificity of 78.7%, PPV of only 35.0% and NPV of only 76.2%. Thus an elevated white cell 
count in cirrhosis is poorly predictive of infection, while a normal white cell count may be 
associated with infection in 25% of cases. 
Coagulopathy 
The platelet count was reduced in most of our patients, and the INR was elevated in 75% 
(Table 3.15). In cirrhosis, a low platelet count is related to hypersplenism and to the direct 
effects of alcohol on platelets. The raised INR reflects impaired liver synthetic function. All 
coagulation factors are synthesised by the liver except Factor VIII which originates from 
extrahepatic sites as well (Conn & Attenbury 1993). These results are compatible with an 
advanced degree of cirrhosis in our study population. Neither the INR nor the platelet count 
predicted the occurrence of GIT bleeding in this study, suggesting that this complication is 
more dependent on non-haematological factors such as portal pressure (Nevens et al, 1998). 
Comparison with some previous studies 
The biochemical and haematological results in our patients are similar to the results of the 
patients of O'Keefe et al (1981) and Seebaran et al (1988), except that our patients have 
higher bilirubin, aminotransferase and alkaline phosphatase levels. Furthermore, our patients 
were more anaemic and had more severe thrombocytopaenia than the patients studied in 
Durban. This suggests that our patients were more ill than those studied in Durban; it may 
also reflect a rising threshold for admission with shrinking resources over the ten years 
between the studies in Durban and the present. A partial factor may however be our 
exclusion of admissions lasting less than 24 hours, which would exclude the least severe 
illness; this alone is however unlikely to account for the difference. 
COMPLICATIONS OF CIRRHOSIS 
In addition to those major complications of cirrhosis present on and indeed necessitating 
admission, further complications developed in many of our patients during their hospital stay, 
as reflected in Fig 3.6. There was no correlation between the cause of the cirrhosis and the 
overall prevalence of encephalopathy, ascites, infection, SBP or renal failure. 
45 
Gastrointestinal haemorrhage 
This was significantly more frequent in alcohol-associated cirrhosis than in patients with 
another cause (p=0.005, by x\ Patients with both alcohol and viral infection behave like 
those with alcohol alone with a high rate of haemorrhage whilst bleeding was significantly 
less frequent in those with viral cirrhosis alone. 
Infection 
Fever is an extremely poor predictor of infection on admission as shown in Fig 3. 7, despite a 
significant difference in medians; because of the large degree of overlap. The organisms 
grown on blood culture are known to be common organisms causing infection or bacteraemia 
in cirrhosis. In particular, E. coli is the commonest organism causing bacteraemia and SBP in 
cirrhotics; Streptococcus pneumoniae and Klebsiella are also commonly found (Caly & 
Strauss 1993). Only one patient had both a positive blood culture and an ascitic fluid culture; 
surprisingly, the organisms were not the same - Enterobacter from the blood and E. coli from 
the ascites. 
Spontaneous bacterial peritonitis 
Despite current recommendations that a quantitative neutrophil count on ascitic fluid should 
be performed in any decompensated cirrhotic with ascites since it is the most sensitive test 
for SBP, an ascitic fluid white cell count was performed in only 35 admissions, or 53% of all 
those in whom diagnostic or therapeutic paracentesis was done (Table 3.18). Some of these 
may in fact be regarded as inadequately investigated since a differential white cell count was 
not done; it is a neutrophil count greater than 250/ml which offers the most sensitive test for 
SBP (Gaumer & Soriano 1997). Somewhat more (66, or 83%) had fluid submitted for culture. 
It is recommended that ascitic fluid be inoculated directly into blood-culture bottles, which 
increases the positive yield from 50% to about 80% in SBP (Gaumer & Soriano 1997). We 
suspect that this was performed in few of our patients; and is consistent with the observation 
that of the 9 patients in the study recorded as having SBP, only 3 positive cultures (33%) 
were reported. Even this figure is likely to represent an overestimate because the inadequate 
diagnostic protocol for SBP employed in these patients almost certainly underestimated the 
true incidence of SBP. Indeed, only one of the nine labeled as having SBP was correctly 
proven to have SBP with the demonstration of an elevated ascitic fluid neutrophil count. SBP 
was recognised in only 4.4% of our admissions, which is considerably fewer than the 8-27% 
reported in the literature during a single hospital admission (Gaumer & Soriano 1997). 
Other infections 
The total incidence of infection, including SBP, reflected in our patients' folders was 23.2%. 
This is lower than the 30-50% of admissions with infection during hospitalisation in cirrhotics 
quoted in the literature (Navasa et al 1997), again suggesting that a proportion of patients 
with infection were missed. This may be in part due to the poor negative predictive value of a 
normal temperature and white cell count as described above, failure to perform the 
appropriate tests for SBP and a low index of suspicion for infection in cirrhotic subjects. 
PROCEDURES AND INVESTIGATIONS 
The most common procedure performed is a chest radiograph, followed by endoscopy, 
abdominal paracentesis and variceal injections (Table 3.19). The high frequency of 
endoscopy and variceal injection is obviously related to the frequency of gastrointestinal 
haemorrhage in these patients. 
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OUTCOME AND PROGNOSIS 
Of the patients admitted during the years 1993 to 1996, 48.2% had died by early 1997 (Table 
3.20, Fig 3.7) when the folders were reviewed; this may be an underestimate as further 
patients may have died at home or elsewhere, the fact not being recorded in the folder. 
Historically the 4-year survival for decompensated alcoholic cirrhosis, following the 
development of ascites, has been estimated at 30% ( D'Amico et al 1986) and 25% 
(Saunders et al 1981 ), when the observation was made that there had been little change in 
the mortality of cirrhosis over the previous two decades. It is unlikely that there has been any 
major improvement since, though improvements in the recognition and management of SBP 
and gastro-intestinal haemorrhage may have improved the 4-year survival to some degree. 
However, the single factor most likely to have significantly improved survival over the past 
decade has been an exponential increase in transplantation coupled with greatly improved 
graft survival. Significantly, none of the patients in this study was transplanted though two 
were admitted for assessment for transplantation. The unsuitability of these patients for 
transplantation probably relates to their advanced disease, as well as to a shortage of donors 
and the poor social and educational background of many of our patients. 
COSTS 
The costs we have calculated for these patients amount to approximately R2017 per year 
(Table 3.21, 3.22). This is a conservative estimate; same-day or overnight admissions for 
endoscopy, sclerotherapy, paracentesis and biopsy were not included; procedures were 
costed once though in many cases they would have been repeated serially or repetitively, 
and the costs associated with out-patient therapy and with transplantation have not been 
included. Even so, a figure of R2.9 million for the in-hospital treatment of cirrhosis over a 4 
year period is not unimpressive, especially when the true figure may be double that or more. 
IN CONCLUSION 
Prevention of cirrhosis 
In view of the poor prognosis, measures are needed to improve the outcome and to prevent 
the progression of disease in patients with cirrhosis. In our study and those in other 
countries, the cirrhosis in most patients is due to alcohol, second is infection with the 
hepatitis viruses. Alcoholic cirrhosis is by definition preventable; increasingly, viral cirrhosis 
can be avoided by public health measures, by vaccination and potentially by specific antiviral 
therapy. 
Alcohol 
The fight against alcohol abuse in South Afric has not been well organised. Alcohol misuse is 
related to many factors which include easy availability, heavy advertising and societal 
pressure, socio-economic issues such as social class, employment, housing, availability of 
recreation facilities and education, and historical issues such as the "dop" system on farms in 
the Western Cape. A multidisciplinary approach is needed, with tight co-ordination of public 
and private agencies. There is a role for doctors, psychologists, social workers and 
legislators in: 
• improving education and living standards 
• discouraging the glamourisation and advertising of alcohol 
• reducing its easy availability 
• educating the public, and particularly children, about the dangers of its misuse 
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• improving access to healthier recreational activities 
• improving access to facilities for the care and rehabilitation of those addicted to alcohol. 
This is a long-term project. Success with anti-smoking campaigns in some countries has 
suggested that sensible, sustained programmes can modify public behaviour; till this point 
there has not been the same will to tackle alcohol misuse as there has with smoking. 
In reviewing the folders of the patients we studied, we observed with concern that there was 
no formal record of any counselling of the patient with regard to cessation of alcohol. 
Presumably some advice or injunction was given, but there was additionally no record of 
even a single patient having been referred to any agency such as a psychiatrist, alcohol 
treatment centre, social worker or Alcoholics Anonymous despite many of the patients having 
several admissions over the 4 years. This may reflect a resigned and fatalistic attitude on the 
part of the doctors, coupled with an undue pre-occupation with the biological, rather than 
psychosocial dimensions of their patients. Doctors should play a more significant role in the 
early identification of patients with alcoholic liver disease, in treating, counselling and 
referring them to appropriate agencies such as psychologists and social workers for 
treatment. Support groups should be created in communities for people who have problems 
with alcohol abuse as well as making this alcohol abuse a public health problem so that 
employers are able to refer these patients for help. 
Viral hepatitis 
The introduction of a national hepatitis B vaccination programme for children is an important 
step towards reduction of hepatitis B viral cirrhosis, and will greatly add to the modest 
benefits already achieved by the introduction of adult vaccination of high-risk groups, of 
secondary prophylaxis and of screening of blood donations. The benefits of universal 
immunisation will take time to manifest. 
Health education with regard to hepatitis Band hepatitis C viral infection and spread will also 
be helpful. "Safe-sex" campaigns for the prevention of the human immunodeficiency virus 
(HIV), may contribute to a reduction in the sexual spread of hepatitis B and, perhaps, C. 
Because hepatitis B and C viral infection usually present clinically long after the initial 
infection, there is a tendency to underestimate the poor prognosis associated with them. 
Management of cirrhosis 
From this study, it is clear that in many instances there were insufficient recorded data to 
substantiate the aetiological diagnosis assigned to the patient, e.g. lack of information on the 
degree and duration of alcohol exposure, and a low rate of histological diagnosis in patients 
with cirrhosis. In the interests of a better understanding of patients and therefore of better 
management, as well as for the improvement of data collection for further studies and 
quality-assurance assessments of the quality of care, data collection and recording on every 
patient needs to be more systematically undertaken. 
The management of patients with complications of cirrhosis can be improved by conforming 
to modern recommendations. Increasingly evidence-based guidelines are becoming 
available for the prevention and treatment of ascites, encephalopathy, variceal haemorrhage 
and SBP; examples include protocols for primary and secondary prevention of variceal 
bleeding, for the diagnosis of SBP and for prophylactic antibiotic use to prevent it in those 
prone to frequent recurrence. As suggested above, the institution of primary and secondary 
prophylaxis for variceal bleeding might reduce our admission rate. The need to refer suitable 
patients for possible liver transplantation must be widely understood. 
48 
Continuing education of all doctors and health-care workers caring for patients with cirrhosis, 
either in hospitals or in the community, is vital; indeed, the patients themselves should not be 
forgotten, but included as equal partners in their own care. 
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